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Chapter 1
Introduction
Atrial Fibrillation:
The Oldest Arrhythmia - The Newest Disease.
Manias Duytschaever. MD
"77!*" mri/Vm »/«/xif/rnf <Y«Jf/nn/nj? to /iv* »7/A an aiir/c/^ »nra/raMf o/fon/ra<7iV>n -
a /////«• .t/u</v to //
Thomas Lewis (1902).
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Natural History of Atrial Fibrillation
THE OLDEST ARRHYTHMIA
Atrial fibrillation was a cause of speculation by physicians since early times. Initially it
was referred to as rebellious palpitations, delirium cordis and pulsus irregular is pepetu-
us.' In 1902. James MacKenzie provided the first insight into the mechanism of the
pulsus irregularis perpetuus. In the "Study of the Pulse", he published a report showing
that during the irregular heart rhythm the jugular "A wave" was lost. This provided the
first insight into the mechanism of auricular fibrillation. Similar venous and arterial pulse
recordings were made by Cushny. Hdmunds and Lewis in directly observed auricular
fibrillation.'' In I9(W. Thomas Lewis, taking advantage of l-inthoven's newly developed
galvanometer, was the first to establish electrocardiographically that auricular fibrillation
was the cause of pulsus irregularis perpetuus (h'ig. I).' As for auricular fibrillation, along
the way it became "atrial fibrillation" or "atrial fib" and sometimes it is respectfully
referred to as the grandfather of arrhythmias.
rMfc
4=3C
<jn7i»xfti»i.t «•< «»»/<•</ />v 77i«mii.i /.»t'f.i i /um //I* wnui rnwnm in « norm«/ /«((»•«( (H/V>CI /»»»•/J «/«/
iV»i in un«ln<r/urirn/ firmer /xjnc/;. /•/7)ri//<»inAf (/"; n m r i i/rr </<-m»ni/r«/n/
THE MOST COMMON ARRHYTHMIA
With 500 million people in the European Union, and a prevalence rate approaching 2%.
the number of people with AF can be estimated to be around 10 million." The median
age of patients is 75 years with 84% are older than 65 years. The incidence and
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prevalence of AF is expected to increase as the global demographic tide will result in a
marked increase of the elderly population " Indeed, Braunwald, in his Shattuck lecture,
referred to the growing "epidemic" of AF." The genesis of this epidemic is not only due
to changes in the age-distribution of the population. The Framingham study found an
increasing prevalence of AF even after adjusting for age.'" Underlying explanations
remain speculative and may be multi-factorial. Since 10 to 35% of patients with CHF
develop AF, the increasing number of patients with CHF may play an important role."
Indeed, atrial fibrillation and heart failure represent the intersection of two common
diseases, both of which have been labeled "new epidemics".'"' Notwithstanding the
increasing numbers of patients with AK there is a strong likelihood that the incidence
and prevalence of AF are even substantially underestimated. In the Stroke Prevention in
Atrial Fibrillation study (SPAF-III) approximately 45% of patients had AF detected
incidentally when eleclrocardiography was performed for an unrelated reason." In
patients with symptomatic paroxysmal AF. there is a 12:1 ratio of asymptomatic versus
symptomatic episodes." Indeed, Camm referred to silent atrial fibrillation as being
another Pandora's box."
A TROUBLESOME ARRHYTHMIA
Atrial fibrillation has a marked effect on morbidity and mortality. Also its socio-
economic consequences due to hospital admissions, chronic disease management and
disabilities arc substantial. Alrial fibrillation is known to be an independent risk factor
for stroke." '" Overall, it is associated with a 4- to 5-fold higher risk of stroke," and the
major cause of embolic stroke. Besides major thromboembolism, AF is also associated
with intermittent ischemic attacks or even silent cerebral infarcts. According to magnet-
ic resonance images, 4(F/f of AF patients have one or more cerebral infarcts."''" These
may cause develop apparently unaccountable neurological symptoms, ranging from
forgelfulness to frank dementia. The impact of AF on mortality was less clear. However,
recently the Framingham study showed that the presence of AF /W<yvH</<7i//y increased
the risk for death in men (Odds ratio: 1.5) and women (Odds ratio:1.9)." Especially in
patients with l.V dysfunction. AF was found to have a detrimental role. In the Studies Of
Left Ventricular Dysfunction (SOLVD) trials, the presence of AF was a powerful
independent predictor of death due to pump failure and re-hospitalization for CHF.-'
THE NEWEST DISEASE
Although the oldest arrhythmia, for some reasons atrial fibrillation seems the newest dis-
ease. The degree of interest in AF. as distinct from other forms of arrhythmias, has
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increased significantly in recent years. This is illustrated in Fig.2. in which we plotted
the number of full papers on AF published in (7n M/<I/;<»/I from 1450-2(XX). It is clear that
especially during the last decade, research was performed on atrial fibrillation. It is
difficult to say what caught the attention of the cardiologist, arrhvthmologist or physiol-
ogist. One explanation for this may be the fact that the successful treatment of ventricu-
lar arrhythmia and other forms of supraventricular tachycardia turned the aitenlion of
cardiologists to the remaining challenges in arrhythmia management. More likely how-
ever is the increased awareness of the considerable prevalence and morbidity of AF und
that AF is just not an acceptable alternative to nomial sinus rhythm.
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Treatment Options in Atrial Fibrillation:
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In ihc first hall of (he previous century the cornerstones for pharmacological treatment
of AH were digoxin, anticoagulation and quinidine. In "the management of acute cardiac
emergencies" I)e I.a Chapelle el al. give a point of view on the treatment of auricular
fibrillation in 1951." Most clinicians digitali/.cd patients "H7I<> .v/imr ,v/,i;/i.v f*/"/it'</r/y«/7-
H/c *»/• »r/V> //r/\r </ r<J/J/</ vr/ilr/cH/wr ra/V «.v «'.VM// <j/'«H/7<-«/«/'y//jr/7/a/;o/i". In addition,
anticoagulation was administered ".v/mv, wi/A //IM /re«/wi<'/j/ //if /eH</fHfv/or //if Jf/w-
,vi7/f»;i I»//;////«// / /mw//)/ <;«</ //i<'/v/i>r<' (»/" <'ffi/w>//.vwi CM« />nr»/w/>/v />f «//iN/'/i/.v/ift/." To
restore sinus rhythm "//;<• /«/7/«/ / / r « / / m w .V/IOM/J //IC/IM/C />/iv.v/f«/ «/it/ mf/i/a/ r « /
\' mc(i/i.v f>/'« .vct/cifitr f/j/Tp/i'raWv fl /jar/?//Mra//r «ck/ Jfra/i»r). C?M/«/V//>if M
^'«'//»'«' ;>i <y)n\rr/i/ij? / w m n ' s m a / «MWCM/«/"./f/»r/7/«//Vm /« norma/ .VIVIM.V WIVZ/IMI
<;»K/ i.v co//.vi(/<7'<'</ / ) \ wies/ r/im'fiMr'i.v /<» />«' //if r/rw.i; r)/'<7io;Vf /or //i/.v /7Mrpr«f, rf^arrV/f.v.v
<»////<• MHj/fr/vi'/i^ /v/>f (»/ /ifi(/7 <//.vrti.vf."
So at the end of the first half of the previous century, treatment of AF seemed strikingly
similar to actual treatment currently applied in the majority of patients with AF. Also the
incremental benefit of rhythm control was acknowledged.' This was beautifully illus-
trated by Sokolow et al. who showed that cardioversion of AF resulted in marked
clinical improvement, as expressed by a decrease in body weight and circulation time
(l'ig.4. left panel). ' On the other hand. Sokolow et al already documented the pitfalls of
rhythm control of AF (Fig.4. right panel). They showed that the efficacy of cardioversion
by quinidine was limited by (he duration of the preceding AF duration and tha( a high
rate of recurrences of AF occurred during the first week after successful restoration of
sinus rhythm."'
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A main change in the treatment of atrial fibrillation was the introduction of electrical
cardioversion of cardiac arrhythmias in l%2." This non-pharmacological approach
markedly improved the efficacy of cardioversion of long lasting AF up to 90%."
However, its long-term efficacy seemed to be limited by a high rale of recurrences of AF
with only 20-40% of patients maintaining sinus rhythm during the first year.''"'
Both class IA. 1C and III drugs (quinidine. flecainidc. propafenone. sotalol. amiodarone)
were found to prevent recurrences of atrial fibrillation after cardioversion of AF."***
However, despite the use of antiarrhythmic drugs, the recurrence rate of AF remained as
high as 25 to 50% after 1 year (Fig.5)."
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Wo/in/owr rf uA Zrnr/u/^r <•/ a/.
/•7j?u/r 5. /jmi/cJr^irarv a/u/pro-arrAvf/unir ri.tiv of tariVu« j/«11 / an*/ /// anviar-
rfcvfnmir rfruj? f/wra/Hf!/«/• u(nu//i/>r<y/u/i»n. W«'v/7//<' anfiarrAy/Amir OV«KI, u/>cr /
Vfur i"»n/v 50-75^ «//wi/ienM aw ifi// in .wnu.t rnv/A/n. W^rcr/ir/; an//arr/iv/Ami(
m»rta/irv <wmpö/ird /« /
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Moreover, when patients were followed beyond the standard of I year, only 18% of
patients were still in sinus rhythm 5 years after cardioversion.* More frightening was the
observation that the use of antiarrhythmic drugs was associated with a higher mortality.
In 1989. the CAST investigators reported an increased mortality in patients treated with
class I drugs to suppress arrhythmias after myocardial infarction.' '" Also the class III
drugs (d-sotalol) were found to found to carry an increased risk in patients with heart
failure." In patients with congestive heart failure and atrial fibrillation, the use of antiar-
rhythmic drugs was associated with a higher mortality compared to placebo.""*' As a
result, anliarrhylhmic drugs seemed to have both a low efficacy and safety for treatment
of atrial fibrillation (Fig.S).
THE LAST DECADE
The limited efficacy and pro-arrhylhmic risks of antiarrhythmic drug therapies for atrial
fibrillation resulted in a growing interest in non-pharmacological options in the treatment
of AH Current therapeutic developments encompass new antiarrhythmic drugs, the
alrial dcTihrillalor. alrial surgery, linear and focal ablation and preventive atrial pacing
(Fig.6)." All of these interventional options are directed either at prevention or termina-
tion of atrial fibrillation. Clinical investigation of the new class III agents (dofetilide.
a/.imilide. ihutilide. tedisamil, etc..) have shown them to offer incremental benefit over
existing agents. However, the major shortfall remains the potential to cause pro-arrhyth-
mias.'' The internal atrial dcfihrillator in theory is an excellent modality for rapid
conversion of AF." Limited data suggest that early cardioversion prolongs the interval
between recurrent episodes of AF." However, the drawbacks include discomfort from the
shocks and immediate recurrence of AF." Surgical therapy for AF (maze procedure) is
highly successful in patients who require open-heart surgery for another indication.**' In
patients with lone AF or no other indication for surgery, an intra-operative approach for
the treatment of AF seems unattractive due to potential risks, discomfort and prolonged
convalescence. Linear catheter ablation is still hampered by technical problems and
serious complications such as cerebrovascular accidents, cardiac tamponade and loss of
atrial function." * Focal catheter ablation has been shown to be effective in drug-refrac-
tory patients with symptomatic paroxysmal AFV ^ However, after the initial experience,
it became clear that local ablation within pulmonary veins, pulmonary vein isolation or
segmental isolation of pulmonary veins are long-lasting procedures with serious com-
plications (pulmonary vein stenosis, thromboembolism. hemopericardium,...).
Moreover, uncertainty exists about long-term results with regard to AF recurrence and
PV stenosis." Preventive alrial pacing was shown to decrease the likelihood of AF in
patients with vagotonic AF or sinus node disease.'*'" However, atrial pacing can not be
justified in patients without sinus node disease.**
Although the wide spectrum of new approaches seems promising, they can be applied in
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only a minority of patients with AF. In fact, the variety in treatment options may reflect
confusion, similar to the variety of names given to AF in the beginning of the previous
century (Fig.6). Despite all efforts, with a few exceptions, present-day treatment of AF
can still be characterized as 'doing our best without knowing what is wrong". To devel-
op a more effective strategy for treatment of atrial fibrillation, one needs to further inves-
tigate the pathophysiological mechanisms undcrhing initiation and perpetuation of
atnal fibrillation. As Thomas Lewis suggested in 1902: "The notion of a patient contin-
uing to live with an auricle incapable of contraction is a somewhat novel idea...it seems
necessarv to devote a little study to the condition."
.../<i.V/
• Atrial Paralysis
• Delirium Cordis
• Pulsus Irregularis Perpeluus
• Pulsus Arrhythmicus
• Auricular Fbrillation
New Antiarrhythmic Drugs
Atriul IX'fihrillator
Atrial Surgery
Kocal and Linear Ablation
Preventive Atriul Pacing
fij(unr 6. AffM' (nramirn/ <>p»«m /»r /*/• <-n< « m / x m n w iinliurrnvlAm» i/nuyi. //ir
(j/r/u/ </<"/7/>ri7/<i((ir. <»™W vu/jjerv. /<«« / un</ /incur OW<I(/»II <m</ /»»rirn/iir <//ri«/
/wci'nx AWioujun /«<• w i</c iy«"<7r«m .veenu />nim»i'nx. 'Ac wjricfy in Irruimciil «/)(i»n.v
/»m/iuWv rf/7<-<7v rfin/iMiV»i. vimi/ur /o l/ic wirirfy o/numc.« x i i r n lr> ^ F in 'Ac Af(in-
n/nj< o / l/ic /I/KTIVW.V c"«'nl«r\".
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Abstract
Background: Episodes of atrial fibrillation (AF) are known to cause both a rapid reduc-
tion in ulriul refractoriness (atrial electrical remodeling) and a more delayed increase in
AF stability in the chronic goat model. The aims of this study were to examine I) the
hypothesis that an AF-induced increase in AF stability might be due to a mechanism with
a longer onset and offset than that of changes in refractoriness and 2) the possibility that
repeated paroxysms of maintained AF might cause a cumulative increase in AF stability
independent of changes in atrial refractoriness.
Methods and Results: AF was maintained by rapid atrial pacing in 7 goats for three
consecutive 5 day periods, each separated from each other by 48 hours of sinus rhythm.
Assessments of atrial refractory periods, conduction velocity. AF inducibility, and dura-
tion of individual episodes of AF were attempted at intervals throughout the protocol.
Forty-eight hours of sinus rhythm was just sufficient for refractoriness changes to fully
reverse in all goals, with no evidence of any "residual" increase in AF inducibility. There
was no significant difference between any of the 3 periods of pacing-maintained AF with
regard to time to develop episodes of AF of 60 seconds duration (22.1 ±13 hours. 23.8±I6
hours, 3().3±29 hours), I hour duration (56.6±28 hours, 6I.3±31 hours. 60.1±32 hours)
or 24 hours duration (84.0±3l hours, 87.0±33 hours, 83.5±32 hours).
Conclusion: There is no evidence for a cumulative effect of AF paroxysms on AF
inducibility or stability independent of changes in refractoriness. These findings high-
light the importance of atrial refractoriness as a potential target for antiarrhythmic strate-
gies uimed at inhibiting the self-perpetuation of AF.
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Introduction
Atriai fibrillation (AF) has a tendency to become more persistent with time, a large
percentage of patients with paroxysmal AF eventually developing chronic AK' •'
Although progression of an underlying cause is one explanation lor this phenomenon, in
a significant proportion of cases no underlying cardiovascular disease is evident.'
Recently Wijffels and coworkers* have demonstrated, in a chronically instrumented
conscious goat model, that episodes of AF are self-perpetuating ("AI- begets AF").
Induction of AF in this model is accompanied by a marked shortening of atriai refracto-
ry periods and loss of the normal rate-adaptation of refractoriness denned alrial electri-
cal remodeling). It is postulated that these effects increase AF stability by shortening
atriai wavelength and increasing ihe potential number of reentrant wavelets in the atria.'
" These eleclrophysiological changes have a relatively rapid time course, most of the
effects occurring within 48 hours of the onset of AF.' In contrast, the time required for
induced AF to become stable is significantly longer and more variable (from 3 to 20
days).' This time delay between postulated cause and effect has led to the suggestion that
additional factors with a longer time course than the shortening of atriai refractoriness
may play a role in the self-perpetuation of AF. There are a number of potential candi-
dates, including atriai dilatation and changes in atriai structure, which ure likely to tukc
more than 48 hours to develop or resolve.
The primary aim of this study was to examine the hypothesis that an Al-induced
increase in AF stability might be due to a mechanism (a so-called second factor) with a
longer time course than that of change in atriai refractoriness. If this were the case then
it would be expected that the increase in AF vulnerability and stability dial is evident
following a prolonged paroxysm of AF would remain for a longer period than that
required for atriai refractoriness to return to normal. A second aim of the study was to
examine the possibility that repeated paroxysms of AF result in a cumulative increase in
AF inducibility or stability independent of changes in atriai refractoriness. This would
provide a potential means whereby recurrent paroxysms of AF might progress to per-
sistent AF despite full reversal of refractoriness changes between successive paroxysms.
Methods
CHRONIC GOAT MODEL OF ATRIAL FIBRILLATION
Seven female goats were used for this study. Animal handling was performed according
to the Dutch Law on Animal Experimentation and approved by the Animal Investigation
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Committee of the University of Maastricht. The goats were anaesthetised with
Thiopental (15 mg/kg) and ventilated with halothane (1-2%) and a 1:2 mixture of O2
and N2O. A left intercostal thoracotomy was made and the pericardium was opened to
expose the heart. A silicon strip of 10 x 1.2 cm. containing 23 unipolar platinum elec-
trodes (diameter 1.5mm, interelectrode distance 6-l()mm) was guided through the
anterior transverse sinus between the atria and the aortic root and sutured to the tips of
both atrial appendages. In addition, two smaller silicon plaques, each containing 30
electrodes, were sutured to the lateral walls of the right and left atria (interelectrode
distance 5mm). After approximation of the pericardium and closure of the thorax, the
electrcxJe leads were tunnelled subcutaneously to the neck and exteriorised by three
30-pin connectors. Three silver plates (diameter 25mm) were left subcutaneously to
serve as grounding and indifferent electrodes and to record a prccordial electrocardio-
gram. Post-opcralivcly the animals received buphrenorphine (Temgesic) for 1-3 days.
Ampicill in (l(NX)mg) was given prophylactically both before and after surgery.
Approximately 2 weeks after surgery the goats were connected to an external auto-
matic atrial fibrillator. The external automatic fibrillator consisted of a personal com-
puter connected to a stimulator (Medtronic SP3084). The software continuously
analysed one of the atrial elcctrograms and as soon as sinus rhythm was detected, a
I-second burst of biphasic stimuli (duration 2 ms. interval 20 ms, strength 4 times
diastolic threshold) was delivered to a pair of atrial electrodes. By these automatic
bursts of stimuli, atrial fibrillation could be maintained continuously 24 hours a day as
has been previously described.''
STUDY PROTOCOL
The protocol for the study consisted of the maintenance of AF for three consecutive 5
day periods, each separated from each other by a weekend (48 hours) of sinus rhythm.
Pilot studies had indicated that after 5-days of maintained AF. a period of 36-48 hours of
sinus rhythm was required for refractoriness to return to control. Assessment of the atri-
al refractory period, conduction velocity. AF cycle length, and AF inducibility (right and
left atria), was attempted during baseline and after 6, 12, 24,48, 72, % and 120 hours of
maintained AI- (Figure I). The duration of individual episodes of AF (the time between
2 atrial pacing bursts) was recorded automatically on a personal computer. If AF did not
terminate spontaneously within 6 hours at the end of 5 days, sinus rhythm was estab-
lished by external IX ' cardioversion. Following return to sinus rhythm, the refractory
period and AF inducibility were measured 24 and 48 hours post-cardioversion.
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MEASUREMENTS
The atrial effective refractory period (AHRP) was measured at sites on the left ami right
atria (selected on the basis of good signal recording and low stimulation thresholds) due
ing a basic pacing drive of 4(K)ms. A single premature stimulus (4 times threshold) wus
interpolated at every fifth basic interval and. starting from well within the refractory peri-
od, the SI-S2 coupling interval was incremented in steps of lms. The shortest S1-S2
interval resulting in a propagated atrial response was taken as the AFRP. Intra-atrial
conduction velocity was calculated from conduction times recorded at the atrial free wall
during regular pacing (4(X)ms drive) from the left or right atrial appendage, the inter-
electrode distances calculated from the known inlerclectrode dimensions of the silicon
electrode plaques. Mean atrial fibrillation cycle length (AFC'L) was determined during
induced AF from a sample of 3(X) cycles using an automatic detection algorithm which
was validated by periodic manual confirmation and continuous display of AF interval
histograms.
The inducibility of AF was assessed by the response to single premature stimuli deliv-
ered during a 4(X)ms drive at the AERP. Atrial fibrillation was considered to be induced
if the single premature stimulus was followed by rapid irregular atrial activity lasting for
more than one second on at least 2 of 3 attempts.
DATA ANALYSIS
Data are presented as mean± standard deviation. Statistical analysis of the paired data
was performed using the Student's t-test and in the case of multiple statistical compar-
isons the p value was corrected by multiplying it with the number of comparisons. A
corrected p value of less than 0.05 was considered to be statistically significant.
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Results
ATRIAL REFRACTORINESS
Atrial electrical remodeling (defined in this study as a reduction in atrial refractoriness
measured during a 400 ms drive) occurred in all 7 goats in the study, the greatest reduc-
tion in refractoriness occurring within the first 24 hours. Measurements of refractory
periods were possible in all goats for the first 24 hours of maintained AF. Because the
duration of AF episodes became more sustained after this time, the opportunities to
measure refractory periods became less. As a result, in only 4 of 7 goats could atrial
refractory periods be measured at 48 and 72 hours, in 2 of 7 at 96 hours and in only one
goat at the end of (he 5 day period of AF. In Figure 2 refractory period measurements at
the right and lefi atria (mean values all goats) are plotted during the 3 successive 5-day
periods of AI- Following both the first and second periods of AF. atrial refractoriness had
returned to baseline values (+.W) after 48 hours of sinus rhythm in all 7 goats. No
significant differences were seen either in the degree (absolute values achieved) or the
rale of remodeling between the 3 successive periods of AF. In other words no evidence
couUl be found of any preconditioning by previous episodes of AF on the process of
atrial electrical remodeling.
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CONDUCTION VELOCITY
Measurements of atrial conduction velocity were limited to 4 of the 7 goats (left atrial
free wall only), because of lack of high quality recordings from chronic electrodes
perpendicular to the activation wave during pacing. As with measurement of atrial
refractory periods, conduction velocity measurements could always be made for the first
24 hours of maintained AF (each of the 3 episodes) bul thereafter, because of the high
inducihility of prolonged episodes of AF. measurements became more sparse. There was
no evidence of a cumulative effect of episodes of pacing maintained AF on conduction
velocity in the left atrium (Figure 3). Mean conduction velocity at the start of each of the
3 periods of maintained AF was 132±29 cm/s. I22±29 cm/s and I2I±5() cm/s (no
significant difference). The corresponding values after 24 hours of each of the 3 periods
were 134±23. 136±26 and 115±36 (no significant difference).
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CYCLE LENGTH OF INDUCED AF
The shortening of atrial refractoriness was associated with a concomitant shortening of
mean AF cycle length (Figure 4) in all goats. There was no evidence of a cumulative
effect of episodes of pacing maintained AF on the cycle length of the induced episodes,
either in terms of absolute changes or their rate of development.
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INDUCIBILITY OF AF
The effects of the 3 pericxls of maintained AF on AF inducibility with single premature
stimuli arc detailed in the table. Inducibility at the beginning of the first, second and third
periods was 3o'/<. 21'/} and 43'/< respectively. The corresponding values after 12 hours
of pacing were 86'7r. 86% and 86%. and after 24 hours of pacing were 100%. 100% and
93%. Beyond 24 hours, inducibility of AF was universally 100% whenever it could be
tested. This increase in inducibility with duration of maintained AF was evident in all 3
periods of AI- and there was no evidence of any "residual" increased inducibility after
return of atrial refractoriness to baseline values. There was no evidence of a cumulative
eflect of repealed episodes of maintained AF on AF inducibility.
STABILITY OF AF
The stability of AF. as measured by the mean duration of individual episixles of induced
AF. increased over each 5-day period of maintained AF in all goats, but in no goat was
there evidence of a cumulative eflect of repeated episodes of maintained AF. There was
a wide variation in AF stability between individual goats (Figure 5). In terms of the
pooled results (Figure 6) there was no significant difference between any of the 3 peri-
ods of maintained AF with regard to time to develop episodes of AF of 10 seconds dura-
tion (6.8±I2 hours. 1O.3±I4 hours. 8.8±l 1 hours). 60 seconds duration <22.I±I3 hours.
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238±16 hours. 30.3±29 hours). 1 hour duration (56.6±28 hours . 6l.3±3l hours.
60. l±32 hours) or 24 hours duration (84.0±31 hours. 87.0±33 hours. 83.5±32 hours). AH
stability returned to baseline values within the two 48 hour periods ol sinus rhythm in all
goats, with mean durations of individual episodes of induced AH being l2.6±IOs.
IO.4±8.5 s. and 14.2±l5s (not significantly different) at the beginning of each of the 3
periods of pacing-maintained AH.
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Discussion
THE MAIN FINDINGS
The principal findings of this study are I) electrical remodeling and its reversal is a rapid
and reproducible process in goat atria. 2) recovery of post-AF atrial vulnerability does
not have a longer lime course than the time course of reversed electrical remodeling, 3)
recurrent episodes of atrial remodeling do not have a cumulative effect on AF stability
or inducibility independent of changes in refractoriness.
IS THERE A SECOND FACTOR?
One of the aims of this study was to examine the hypothesis that a so-called second
factor with a longer time course (with respect to both onset and offset) than atrial electri-
cal remodeling has an important role in the self-perpetuating nature of AF. If this were the
case, (hen the increase in AI- vulnerability and stability following a prolonged paroxysm
of AI ' should endure lor a longer period of time than required for reversal of atrial refrac-
toriness. This turned out not to be the case. After a 5-day period of maintained AF, 2 days
of sinus rhythm were not only sufficient for reversal of atrial refractoriness but also for full
normalisation of both vulnerability and stability of AF. In other words no evidence was
found for a second factor with offset kinetics slower than those of AF-induced changes in
atrial refractoriness. This suggests that either I) small progressive changes in atrial refrac-
toriness occurring after the first 4K hours of AF are responsible for further increases in AF
stability or 2) there is a second factor with slow onset but rapid offset kinetics.
The possible candidates for a second factor include atrial dilatation, increased spatial dis-
persion of refractoriness and changes in conduction properties of the atria. Patients with
longstanding lone AF usually have dilated left atria and an increase in atrial "area" would
be expected to increase AF" stability according to Moe's multiple wavelet hypothesis.
However patients with brief (< 2weeks) or moderate (2-6 weeks) duration of AF do not
have a measureahlc increase in atrial size.* In contrast to atrial si/e. atrial mechanical
systolic function is affected by short episodes of AFV Even brief (< 2wceks) episodes of
AF result in depressed peak A wave velocity and percent A-wave velocity, these changes
being largely reversible within 24 hours of restoration of sinus rhythm. Longer episodes
of AF R'sult in depression of atrial systolic function that is more persistent, indicating that
it is the AF rather than (he IX ' shock that is the important factor in terms of altered
systolic function. Animal studies have indicated that AF-induced atrial dysfunction has
both u rapid onset and offset and is inhibited by calcium channel blockade." implicating
cvtosolic calcium overload as the cause. Atrial electrical remodeling is also inhibited by
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calcium channel blockade. 10. 11 and it is likely that AF-induccd atrial systolic dysfunc-
tion and electrical remodeling are expressions of the same phenomenon, rather than
systolic dysfunction being a "second factor" with a different time course.
An increase in dispersion of atrial refractoriness might be expected to be a good candi-
date for a "second factor" but previous work with the gout model of AI- has indicated (hat
dispersion decreases rather than increases during pacing-maintained AF.' Nevertheless
refractoriness was measured in only a few sites and in theory it would only require a
single site to fail to remodel (or remodel to a lesser degree) for dispersion of refractoriness
to increase as AF became more prolonged. For dispersion of refractoriness to increase
beyond the initial 24-48 hour period one would have to hypothesise that a) refractoriness
is actually continuing to fall in SOUK* areas (i.e. not a second factor at all) or b) refractori-
ness increases in some cells after (his period, a phenomenon that has yet to he demon-
strated convincingly in the first few days of AF. Finally, one can speculate thai changes in
conduction properties of alrial tissue might take several days to develop and provide a
means whereby AF might become increasingly stable. Studies in dog models of atrial
fibrillation have shown decreasing conduction velocity in the atria' and prolonged surface
P wave duration" after prolonged periods of high rate atrial pacing, (iaspo and cowork-
crs' have demonstrated that this atrial pacing-induced conduction slowing in dogs has a
slower time course than that of atrial refractoriness change and suggest that this ell eel may
constitute a "second factor". This reduction in conduction velocity is ass«>ciated with a
decrease in sodium current (INa) density in dog atrial myocytes. AF duration being relat-
ed lo INa density in each dog." Interestingly, no changes in atrial conduction velocity have
been seen after episodes of pacing-maintained AF in goats. Wijffels and coworkers4 found
no depressive effect of 1-4 days of AF' on intra-atrial conduction velocity measured along
a row of electrodes sutured onto Bachman's bundle. In the current study relatively limited
measurements of left atrial conduction velocity were made but there was no evidence of a
cumulative effect of AF paroxysms on this parameter. This apparent lack of effect of AF
on atrial conduction characteristics may represent a real species difference in atrial elec-
trophysiology between dogs and goats.
This study does not give information on potential contributors to AF stability for episodes
of AF lasting longer than 5 days. Prolonged episodes (several weeks) of high rate atrial
pacing in both dogs" and goats" have been shown to cause marked changes in alrial
myocyte structure and significant increases in atrial diameter. Preliminary results of ultra-
structural studies of fibrillating goat atria have indicated that it may take over one week of
maintained AF before morphological changes occur."' It would not be surprising if such
changes had an additional influence on atrial elcctrophysiology over and above that of
electrical remodeling which might contribute to the perpetuation of AF'. The 5-day period
was chosen because in previous experiments an increase in AF stability was clearly
demonstrable after this period of maintained AF. Indeed, in 5 of the 7 goats in this study
the indiv idual episodes of induced AF were lasting longer than 24 hours by this time. So
although a contribution from structural factors is likely in longer lasting AF. it is clear that
such factors are not necessary for AF to become stable in the goat model.
34 Chapter 2
CELLULAR MECHANISMS OF ATRIAL ELECTRICAL REMODELLING
In the original study of Wijffels et al.' atrial electrical remodeling induced by main-
taining AF for long periods was shown to have a rapid onset (most of the effect occur-
ring in the first 2 days) and be completely reversible within less than one week of
resumption of sinus rhythm. The current study has demonstrated that, for episodes of
AF maintained for 5 days, electrical remodeling is fully reversible within 48 hours. This
time course of onset and offset of electrical remodeling has implications for the under-
lying cellular mechanisms involved. Very short-term metabolic changes, such as
changes in ionic pump activity or phosphorylation of ion channels, are unlikely to be
the underlying mechanism. Similarly, long term structural changes are not likely to be
implicated. In contrast, processes leading to altered gene expression of ion channel
proteins would be expected to have a lime course of onset and offset similar to that of
electrical remodeling demonstrated in this study. This would be consistent with studies
in human and dog atrial myocardium that have shown changes in ion channel expres-
sion occur in chronic AI- (associated with reduced expression of Kvl .5 alpha subunit
proteins and a decreased outward potassium current density)'' and alter prolonged rapid
atrial pacing (results in a reduction of densities of the transient outward current [Ito]
and I. type calcium current |ICa | ).'"
RELEVANCE TO CARDIAC MEMORY
The term "cardiac memory" has been used to describe the persistence of T wave changes
ufter termination of ventricular pacing, left bundle branch block or ventricular preexci-
tation'' and it has boon suggested that an atrial equivalent of this phenomenon may have
relevance to the mechanism of airial electrical remodeling and its reversal following
termination of atrial fibrillation. Certainly the development and persistence of altered
rcpolarisalion in response to increased rate and/or changed electrical activation sequence
is a shared feature. In a canine heart model of cardiac memory such changes are abol-
ished by pretrealment with 4-aminopyridine. a blocker of the transient outward current
(Ito). •" consistent with the participation of specific potassium channels in the develop-
ment of the memory phenomenon. Kat/ ' discussed the modification of potassium chan-
nels as a basis lor cardiac memory and summarised evidence for altered gene expression
determining the structure and function of ion channels as an important mechanism for
changes in cardiac repolarisation. Supporting this view are the observations that alter-
ations of the activation sequence can lead to altered wall motion and stretch and that cell
deformation can modify protein synthesis by stimulation of stretch-activated channels."
A key aspect of the original observations of cardiac memory was the increased magni-
tude and slower regression of T wave changes when the heart was exposed repeatedly to
the changes in ventricular activation sequence ("accumulation").'" Del Balzo and Rosen
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20 demonstrated accumulation in the open-chest anaesthetised dog subjected to 3
discontinuous 20-minute periods of right ventricular pacing, each separated by a period
of normal conduction sufficient for T wave changes to return to control \allies. They
noted that the magnitude and duration of the post-pacing T wave changes increased with
each successive pacing period. These findings are clearly in contrast to those of the
current study, in which there was no evidence of accumulation of either the remodeling
process itself (refractoriness changes) or the rate of development of stable AF. Clinical
studies also indicate that cardiac memory has a much slower offset than atriul remodel-
ing, with T wave changes remaining weeks or months after cessation of pacing. This
difference in time course argues against a common mechanism.
ABSENCE OF A CUMULATIVE EFFECT OF AF PAROXYSMS
The absence of any demonstrable cumulative effect of short AF paroxysms independent
of atriai electrical remodeling in the goat has significant implications. As long as there
is sufficient time between paroxysms of AF to allow atriai refractoriness to return to
normal, the substrate for AF is not altered and paroxysmal AF would not be expected to
progress to chronic AF. In addition to the possible clinical importance of these observa-
tions (see below), this high degree of reproducibility of the remodeling process and lack
of cumulative effects indicates that the model is suitable for experimental study of poten-
tial inhibitors of the process.
CLINICAL IMPLICATIONS AND LIMITATIONS
The current study has demonstrated that (he general concept of "AF begets AF" is only
likely to apply to recurrent paroxysmal AF if there is insufficient time between parox-
ysms to allow for full reversal of atriai electrical remodeling. This would imply that the
development of chronic or permanent AF might be prevented by aggressive treatment of
patients with very frequent paroxysms of AF with therapies aimed at either increasing
the time between episodes or accelerating recovery from electrical remodeling. Of
course the extent to which the remodeling process, as demonstrated in the goat, applies
to the clinical situation is unknown and the results of the current study (particularly in
terms of time required for recovery of remodeling) cannot be extrapolated directly to
humans without further clinical studies.
This study was not designed to examine the question of why some individuals (goats or
humans) are more susceptible to AF-induced electrophysiological changes than others
and this aspect of the process remains to be investigated.
Table l. Effects of Maintained Atria] Fibrillation on Inducibility of Atrial Fibrillation With Single Premature Stimuli.
Goats
1
2
3
4
5
6
7
Pacing
Site
RA
LA
RA
LA
RA
LA
RA
LA
RA
LA
RA
LA
RA
LA
All Goats
FIRST PERIOD
SR After 12 After 24
Hours Hours
+ + +
+ +
+ +
+ + +
+ +
+ + I
5/14 12/14 14/14
(36%) (86%) (100%)
SECOND PERIOD
SR After 12 After 24
Hours Hours
+ + +
+ + +
+ +
+ +
+ + +
+ +
+
3/14 12/14 14/14
(21%) (86%) (100%)
THIRD PERIOD
SR After 12 After 24
Hours Hours
I I
+ + +
+ +
+ +
+ + +
+ + +
- + I
6/14 12/14 13/14
(43%) (86%) (93%)
+ = inducible; - = noninducible: LA = left atrium: RA = right atrium: SR = sinus rhythm.
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Abstract
Background: Electrical remodeling of the atria due to fibrillation (AF) creates a sub-
strate for perpetuation of AF. In the present study we evaluated the effect of electrical
remodeling on the window of inducibility (WI-AF) and the substrate of initiation of AF
by single premature beats.
Methods: In 7 goats AF was maintained for 2 days by burst pacing. After 24 and 48h of
electrical remodeling WI-AF was determined at 7 atrial sites at the right (RA) and left
atrium (LA) and Bachmann's bundle (BB). During regular pacing (Sl-SI:4(X)ms), the
upper and lower limit of inducibility of AF (ULI-AF. LLI-AF) by a single premature
stimulus (SI-S2) were determined. Dispersion in atrial refractoriness (DISP-AERP) was
defined by the difference between the shortest and longest AERP. The zone of conduc-
tion delay (CDZ) of premature beats was determined by mapping of RA, LA and BB.
Results: In all goats. 2 days of AF resulted in a marked (3 to 15-fold) widening of WI-
AF. Due lt> AF-induccd shortening of refractoriness, LLI-AF decreased at all sites
whereas ULI-AF remained constant (± 150ms). Widening of WI-AF was not due to an
increase in DISP-AERP (66±2lms vs 76±l6ms. p=0.37) or CDZ (73±25ms vs
88±26ms. p=0.38). Both in normal and remodeled atria, premature beats were associat-
ed with a similar /.one of critical conduction at the mid-portion of BB. However only
after 48h of AF. due to the short AERP. the presence of critical conduction at BB result-
ed in reentry and initiation of AF.
Conclusions: In the goat, electrical remodeling by two days of AF is associated with a
marked widening of (he window of inducibility of AF by premature beats. AF paroxysms
could now be initialed by both short and late coupled premature beats. Widening of the
window of inducibility was not related to an increase in dispersion of refractoriness or
the /.one of conduction delay/block of premature beats. Instead, enhanced vulnerability
to AF could be explained by the higher likelihood of uni-<//npt7iV>/ui/ block and reentry in
remodeled atria.
Key-words: Fibrillation-Electrophysiology-Vulnerability.
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Introduction
New approaches to treat human atrial fibrillation are evolving rapidly.' Part of those
strategies (preventive atrial pacing, surgical ma/e. linear ablation, pulmonary vein abla-
tion, antiarrhythmic drugs) is directed at the prevention ol the (»ir/or/d/i ol atrial fibrilla-
tion (AF). However, despite a significant reduction of paroxysms of AF, in many cuses
recurrences still frequently occur. Gaining more insights into the pathophysiological
mechanisms of the initiation of AF might help to increase the efficacy of prevention of
AF. In humans paroxysms of AF are elicited by atrial premature beats or by a repetitively
discharging focus.'"' The actual mechanism of initiation of AF by these "triggers" is Mill
unclear. Also little is known to what extent AF-induced electrical remodeling plays a role
in the development of a substrate for initiation of AF."
In the present study, we determined the effects of AF-induced electrical remodeling in
(he goat on the initiating mechanisms of AF by single premature beats. Both for right and
left atrial premature beats, we determined the tuWmr <»/ />I</I/(77>;7/'M' of AT before and
after 1-2 days of atrial fibrillation. Programmed electrical stimulation was used to meas-
ure dispersion in atrial refractoriness and the zone of conduction delay of premature
beats. The mechanism of initiation of AF was evaluated by mapping.
Methods
THE GOAT MODEL OF AF
Seven goats weighing between 42 and 58 kg (5()±6) were used for this study. Animal
handling was carried out according to the European Directive for animal research. The
study was approved by the ethical committee of the university of Maastricht. After seda-
tion with Nesdonal (15mg/kg I.V.) the animals were anaesthetized by halothane (I to
2%) and a mixture of O, and N,O. The chest was opened through a left intercostal tho-
racotomy and three teflon felt plaques, each containing 23-30 silver electrodes, were
sutured to the atria (Fig. I). A rectangular plaque (3 x 2.5 cm, 30 electrodes, inter-clcc-
irode distance 4 mm) was sutured on the free wall of the right (RA) and left atrium (LA).
A strip of 6 x I cm. containing 23 electrodes (intcr-clectrodc distance 6-10 mm) was
pulled through the space between the aortic root and Bachmann's bundle (BB) and
sutured to the tips of the atrial appendages. A silver plate was sutured subcutaneously to
serve as indifferent electrode. The electrode leads were tunneled to the neck and exteri-
orized by three 30-pin connectors (Lemosa®). Post-operativcly the animals received
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buprenorfinc (Temgesic®) for 1-3 days. Ampicilline (1000mg) was given prophylacti-
tally ontc before and after surgery. The experiments were started 3-4 weeks after sur-
gery. A fibrillation pacemaker was used to maintain atrial fibrillation for 48 hours. A
custom made computer program automatically delivered I-second bursts of stimuli (50-
Hz) to a pair of atrial electrodes as soon as sinus rhythm was detected.
LA
LA
RA,
RA,
Ai^H/v / /^«'d/i'.Mijiui «A;/if f/iictin/iu/ <•/<•< mx/i v. .Yrimit/u/iun 11 ui /«•//»r/ncd u/ 7 <ifri'u/ijfri (if
(Ar ri'v/ii (i/rii<m (K/W <m</ /MJ) dm/ /<•/; u/ni/m ( M / um/ £A2) aik/ /Ar n>A» fßÄÄA mit/
«nJ /</( (SÄ/.; /HirtJ o/But Amu/in '5'
DATA ACQUISITION
After amplification (MK)x) and filtering (l-5(X)Hz) all unipolar atrial electrograms were
stored on tape. The spatial propagation of depolarization waves was reconstructed by
custom made mapping software. Local activation times were determined automatically
by an algorithm delecting the maximal negative slope of the electrograms. Isochrones
were drawn manually at 5 or 10ms intervals.
EXPERIMENTAL PROTOCOL
In each animal, the protocol was performed before and after 24 and 48 hours of AF-
induced electrical remodeling. Measurements were performed at least 10 minutes after
spontaneous termination of a paroxysm of AF. The atria were paced by biphasic stimuli
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of 2ms duration generated by a constant current stimulator (Medtronic SP3I11). The
minimal current intensity required for capture during slow pacing was taken as the
stimulation threshold.
The window of inducibiiity of AF by single premature beats (Wl-AF) was determined at
7 atrial sites (RA,;RA.;LA,:LA..:BB,,:BB„;BB|) (see Fig.I). During regular pacing with
an interval of 4(M)ms. premature stimuli (S1-S2.4x threshold) were applied, starting with
a coupling interval of 250ms. Each coupling interval was repeated 3 times and then
decremented in steps of 5ms. Induction of AF by a single premature stimulus was
defined as a rapid irregular atrial activity lasting for more than 2 seconds. The upper limit
of the window of inducibiiity (ULI-AI) was determined as the longest SI-S2 coupling
interval resulting in AF. The lower limit (LLI-AF) was defined by the shortest SI-S2
interval that induced AF.
The atrial effective refractory period (AF.RP) was determined during regular pacing with
an SI-SI interval of-MXJms. After every 8"" basic stimulus, premature stimuli (SI-S2. 4x
threshold) were interpolated, starting with a coupling interval well within the refractory
period. Incrementing the coupling interval in steps of 2ms. the shortest SI-S2 interval
resulting in a propagated atrial response was taken as the AliRI'. Spatial dispersion in
AERP (DISP-AERP) was defined as the difference between the longest and shortest
AERP measured at the 7 pacing sites.
The zone of conduction delay of premature beats (CDZ) was determined during prema-
ture stimulation at RA, and LA,. The longest S1-S2 interval associated with an inlra-atri-
ul conduction delay of > 10ms. was taken as limit for conduction delay. Mapping of RA,
LA and BB was used to partly reconstruct the activation pattern of the premature beats
and initiation of AF.
STATISTICAL ANALYSIS
Data are presented as mean ± SD. Statistical analysis was performed by the paired
Student's t test. A p-value of less than 0.05 was considered as statistically significant.
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Results
WIDENING OF THE WINDOW OF INDUCIBILITY DURING 48 HOURS OF AF
During the first 48h of AF, we observed a marked widening of the window of inducibil-
ity of AF by single premature beats. A representative example during premature stimu-
lation at RA, is shown in Fig.2. Due to the AF-induced shortening of atrial refractori-
ness, after 24 and 48h of AF paroxysms could be initiated by earlier premature beats
(lowering of LLI-AF from 126ms to 96ms to 68ms). On the other hand the longest SI
S2 interval that could induce AF was not changed during the 2 days of electrical
Window of
Inducibility
Control
(no remodeling) 29ms
After 24h
ofAF 54ms
After 48h
ofAF
82ms
Mn* -
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remodeling (UL1-AF: from 155ms to 150ms to 150ms). As a result, the window of
inducibility widened from 29m> during control 10 54ms and 82ms alter I and 2 days of
AF. In Fig.3. the window of inducibility of AF of the right and left atrium is plotted for
all goats. At the right atrium (left panel). WI-AF widened from 20± 14ms to 4S±*)ms after
24hof AF(p<0.01)and 73±I5 alter 48h of AF(rx().()l). At the left atrium (right panel).
WI-AF widened from 8±15ms to 41±18ms (rxO.OI) and 62±15 (p<0.0l). In both cases,
widening of Wl-AF was due to a significant shortening of LL1-AF (rxO.OI) while ULI-
AFremained constant (p-value ranging from 0.30 to0.87). In Table I. the mean I.I.I-AF.
UL1-AF and WI-AF are given for all 7 atrial sites. Two days of AF resulted in a 3 to more
than 15-fold widening of WI-AF. In all cases widening of WI-AF was due to shortening
of LLI-AF (rxO.OI) whereas ULI-AF remained constant. The LLI-AF was determined
by the local AERP. whereas ULI-AF was independent of the site of premature stimula-
tion. At (he mid-portion of Bachmann's bundle (BB^I premature stimuli never elicited a
paroxysm of AF.
Right Atrium
Sl-S2(ms)
IN) T
14(1
120
UN)
HO
Ml
40
n.s.
n.s.
24 4X
Hours of AF
Left Atrium
n.s.
ULI-AF
62 W M F
LLI-AI-
24 48
Hours of AF
?.». /"(wjerrs.wif HK/F/II/IX »/»/if nmJmi 0/ jm/ur/M/iry <>//4f f 7 j?waM/ Ay Jlfiff/r pn-m«/«/»- .tn'mu/j u/y>//>(/«/
/Ar ritf/H <;n</ /f/f mniun.
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SPATIAL DISPERSION OF REFRACTORINESS BEFORE AND AFTER
REMODELING
We hypothesized that the upper limit of inducibility was determined by the longest
refractory period present somewhere in the atria. In Fig.4 we plotted the mean AERP at
7 alrial sites before and after remodeling (7 goats). During control (left panel), AERP at
BB„ (I86±9ms) was significantly longer (rxO.OI) than the AERP at RA, (130±l4ms),
RA, (I46±l8ms). BB„ (I48±l8ms). BB, (I36±24ms). LA, (14()±l4ms) and LA,
(l3K±IKms). There was no significant difference between the other 6 sites. The spatial
dispersion in AERP was 66±21 ms. After electrical remodeling by 48h of AF (right panel)
the AF.RP was (equally) shortened at all sites. As a result, the AERP at the middle por-
tion of BB (I46±l6ms) was still significantly longer (p<().()l) than at each of the other
6 atrial sites (RA,:74±l4ms; RA,:83±17ms: BB„:85±16ms; BB,:98±33ms:
LA,:84±l5ms; LA,:83±I lms). The spatial dispersion in AERP in the remodeled atria
was not significantly different from control (76±l6ms, p=().37).
Control (no Remodeling) After 48h of AF
W)
40
L 2(M)
DISP: 1«,
66ms
1:0
80
40
RA, RAj BB„ BB„ BB, LA, LA, RA, RA, BB„ BB„ LA, LA,
/,4A f 7 <^
,\i,i,»ni/icun//v
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CONDUaiON DELAY OF PREMATURE BEATS BEFORE AND AFTER
REMODELING
In all goats, single premature beats elicited in the right and left atrium were associated
with preferential conduction delay at the mid-portion of Bachmann's bundle. In the left
panel of Fig.5 the AI-A2 intervals along BB (BB* and BB,) in response to SI-S2 stim-
ulation at RA, arc plotted. Due to AF-induced electrical remodeling. AHRP had short-
ened from 120ms during control to 82ms after 48h of AF. Both in normal and remodeled
atria, at long coupling intervals (>20()ms) premature beats conducted without conduction
delay along BB (A1-A2,,,,,=AI-A2HHK). However, whereas during control progressive
conduction delay (A1-A2BHI>A1-A2„HR) became apparent at SI-S2 intervals <2(X)ms, in
remodeled atria conduction delay occurred only at SI-S2 intervals <lo()ms.
In the right panel of Fig.5. the conduction lime along BB in rcs|X)iise to SI-S2 stimula-
tion at RA is plotted for 7 goats. The relative prematurity of the S1-S2 interval is defined
as the degree of prematurity relative to the AF.RP (SI-S2 interval - Al-RIM. Both during
control and after 48h of AF. premature beats were asswiated with similar intra-atrial
conduction delay. In both cases, with increasing degree of prematurity a progressive
increase in conduction time from 30ms to 85ms became apparent. In normal atria, the
/one of conduction delay of RA premature beats was 73±25ms compared to 88±26ms
after 48h of AF (p=0.38). Also for LA premature beats CDZ had not changed alter 48h
of AF (62±14ms vs 74±18ms, p=0.36).
Al-A2atBB
(ms)
240
200
160
120
80
O Control
Afer48horAF
BB.
BB„
Conduction lime along
BB(ms)
I00
60
40
20
80 120 160 200 240
Sl-S2(ms)
AKRP +20 +40 +«) +H0 +l(»l +120
Relative SI-S2 (ms)
f!40
ttjfu/r 5. Z^/r/janW: rr/Hrorn/aft'ir /4/-/42 runci u/ontf ffB</i/rin^ .S7-.S2/Nw/nx a//M. .Vrr / «
/wnr/. mran «wu/ur/inn rime a/«n# Äß/»r 7 ^ oä/v. 7Vi<- /ircm«(ur//> »///«• .V/-.V2 inlrnal
o/pnrmunirf/v rr/arirr f» //if .4/-./fP (.V/-.V2 infrnu ' fcraf.«
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CRITICAL CONDUCTION AND REENTRY BEFORE AND AFTER
REMODELING
In all goats we observed that due to AF-induced shortening of atrial refractoriness, in
remodeled atria critical conduction at BB„ resulted more readily in reentry of the pre-
mature beat and initiation of AF. A representative example is shown in Fig.6. The unipo-
lar electrograms were recorded at RA. BB„. BB„. BB, and LA. In normal atria (left
panel), a premature beat with a relative coupling interval of 50ms was associated with
preferential conduction delay at BB„, as evidenced by an increase in conduction time
Cont ro l (no Remodeling) After 48h of AF
RA
BB,
LA
ft ('/ri/xi/iir r/rc mi.vnim.t nrr<>n/n/ <H /M. SSR. BBAf. fi/?/« «n«/ £A /n n«nno/ <i/riu. (ri/i<a/ riWurfion «r
<><•» »101 nwi/f in im7iVm<>» <>//A£ »/icmjj in nvmw/r/«/ 11/n
rrrnlrv «/ii/ f/n/iiiitfM (>/ .4/*.
aloni; BB and fragmented, low amplitude electrograms recorded at BB^,. However,
despite the presence of critical conduction and fragmentation at the mid-portion of BB.
this premature beat did not evoke AF. After 48h of AF (right panel), a premature beat
(relative SI-S2: 50ms) was associated with similar conduction delay and fragmentation
at BBv,. However, now critical conduction at BB„ resulted in reentry and initiation of AF
proximal to the aiva of fragmentation at BB^,. In Fig.7. the corresponding activation
maps of R A. BB and LA are shown. During regular pacing (S1 -S1:400ms) the wavefront
propagated uniformly from RA along BB to LA. The premature beats, both in normal
and remodeled atria, were associated with preferential conduction delay at the mid-por-
tion of BBv, (grey area). In both cases, the left side of BB was activated after a consid-
erable conduction delay of >4()ms. However, only in remodeled atria, critical conduction
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at BB„ was associated with initiation of AF. From the activation map it can be seen that
during the first beat of AF. the earliest activation occurred at BB„ proximal to area of
fragmented potentials. The combination of low-voltage potentials at BBx, and early
re-excitation of BB« strongly suggests that AF was initiated by block and reentry in
Bachmann's bundle. However, the activation maps can not distinguish between micro-
reentry within BB and macro-reentry involving the inter-atrial septum.
The higher likelihood of reentry of premature beats in remodeled atria was observed in
all goats, both during RA and LA premature stimulation. Reentry of the premature heal
could be explained by the short AHRP present in remodeled atria (<l(K)ms). In the pres-
ence of critical conduction, a short AHRP will allow more readily reentry of ihe prema-
ture beat proximal to the zone of critical conduction (uni-(//rf(7iVin(i/ M<>rA). On the other
hand, in non-remodeled atria, despite the presence of critical conduction, a long AI'RP
(>l30ms) will prevent reentry of the premature beat and initiation of Al- (bi-directional
block).
Control (no Remodeling) After 48h of AF
BB, BB, HII, Mil., I'll
Sl-Sl
(4(K)ms)
SI-S2
(AERP+50mM
RA LA
No
Reentry
S I - S I
(4(M)ms)
S1-S2
"(AERP+SOms)
Reentry
(AF)
/r 7. ff</>nr.frn/<i/it'r arfha/iVwi m a p j «>/ AM />r«-m*j/urr /waft frr/wrr a/w/ a/irr r
/<•</ u/rio. /»remu/ure />ro» Brrr asswiulr«/ »>//• < ridrü/ ('»ndWriun o ' //ir « / WW fx/ry «rr«;. //I
« orro
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Discussion
MAIN FINDINGS
In the present study we determined in the caprine model, the effect of 2 days of main-
tained atrial fibrillation on the substrate of initiation of AF by single premature beats. The
main results were as follows. ( I ) In the goat, electrical remodeling by 2 days of AF is
associated with a marked (3 to 15-fold) widening of the window of inducibilily of AF by
premature heals. Due to AF-induced shortening of atrial refractoriness, AF paroxysms
could be initiated by shorter coupled premature beats (shortening of the lower limit of
inducibility). However, electrical remodeling did not shorten the upper limit of inducibil-
ity which remained constant (±l5()ms). (2) In the goat, the mid-portion of Bachmann's
bundle is an area of preferential conduction delay of premature beats. Critical conduction
at the center of BB was associated with fragmented low-voltage potentials at
Bachmann's bundle. The combination of low-voltage potentials together with early
re-excitation proximal to this area strongly suggest that initiation of AF was due to con-
duction block and reentry at Bachmann's bundle. Critical conduction along Bachmann's
bundle could be explained by a considerable longer refractory period at its mid-portion.
(3) In the goat, electrical remodeling by 2 days of AF had no effect on the spatial dis-
persion of atrial refractoriness or the /one of conduction delay of premature beats. As a
result, both in normal and remodeled atria, premature beats were associated with a
similar /one of critical conduction at the mid-portion of BB. (4) Enhanced vulnerability
to initiation of AF by "late" premature beats was due to AF-induced shortening of atrial
refractoriness itself. Due to the short AERP, in remodeled atria critical conduction of
premature beats resulted more readily in reentry and initiation of AF
WIDENING OF THE WINDOW OF INDUCIBILITY OF AF
Previous studies on the window of inducibility of AF by single premature beats were
performed only in non-remodeled atria. In canine hearts, the window of inducibility of
AF was 22±*)ms/ In patients, the "/one of induction of repetitive atrial firing" by apply-
ing single premature stimuli was 23±5ms." Widening of the window of inducibility due
to atrial fibrillation implies a highly vulnerable substrate for (re-»initiation of AF in
electrically aMiuxleled atria. Alter cardioversion of human AF. atrial premature beats
both i w / v ()»</ /<wc in diastole are expected to re-initiate paroxysms of AF. This might
explain the high incidence of recurrences of atrial fibrillation during the first days after
restoration of sinus rhythm.'""
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Although our caprine model of AF can not emulate the more complex substrate in
human atrial fibrillation, the present findings may help to guide and optimise treatment
of atrial fibrillation in patinls. The window of inducihiliiy of AF seems a useful tool to
quantify atrial vulnerability for AF by single ectopic beats. The lower limit of inducibil-
ity is determined by the local AERP, whereas the upper limit of inducibility was inde-
pendent of the site of premature stimulation. Treatment strategies aimed at shortening
of Wl-AF are expected to reduce (he statistical likelihood of recurrence of AF. However,
it remains to be seen whether antiarrhythmic drugs, linear ablation or preventive pacing
can effectively reduce the window of inducibility of human AF.'" On the other, in
patients with a large window of inducibility. the beneficial effect of a treatment short-
ening WI-AF might be negligible and useless. Evaluation of the window of inducibili-
ty in patients would imply Holler monitoring, body surface mapping or programmed
electrical stimulation.
BACHMANN'S BUNDLE: THE "INITIATOR" OF AF
In the present study we observed preferential conduction delay at the center of
Rachmann's bundle. The fragmented low-voltage potentials recorded at Rachmann's
bundle could be the result of non-uniform anisotropy. slow discontinuous conduction,
longitudinal dissociation or conduction block."" Critical conduction along Hachmann's
bundle could be explained by a considerable longer refractory period at its mid-portion.
These findings imply a critical role of the mid-portion of Rachmann's bundle (roof of the
inter-atrial septum) in (he genesis of human atrial fibrillation. Also in human alria, the
inter-atrial septum seems to play a critical role in the genesis of AF. The inler-atrial sep-
tum was found to have the longest atrial refractory period and also to be the area of pref-
erential conduction delay of premature beats.""" More recently, it was shown that in
patients with rheumatic heart disease, earliest activity during induced AF was located
near the inter-atrial septum (ostium of the coronary sinus).'" Treatment strategics aimed
at de-activation of this initiator are expected (o prevent recurrences of AF. In a recent
study in the goat, we showed that pacing at the mid-portion of Hachmann's bundle
effectively reduced the propensity of right or left atrial premature beats to induce AF."
Also in patients preventive pacing at RR seems to have incremental benefit over pacing
at RA.'"-" Likewise, ablation of the mid-part of the inter-atrial septum was shown to
reduce the likelihood of initiation of AF.-' However we want to emphasize that due to
age. dilatation, fibrosis. etc... in patients with AF other areas than the inter-atrial septum
may become the "initiator" of AF."-' Identification of the "iw/7/a/«r" in patients would
imply an electrophysiological study to localize the areas of critical conduction and frag-
mentation and the site(s) of earliest re-activation during AF.
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EFFECT OF ELECTRICAL REMODELING ON THE SUBSTRATE OF
INITIATION OF AF
In (he present study we observed no change in spatial dispersion of refractoriness or zone
of conduction delay of premature beats after 2 days of maintained atrial fibrillation.
Investigators have observed varying alterations in dispersion of AERP after maintained
episodes of high atrial rates.''' ••* •'" Our data are in agreement with previous studies in the
goat reporting that the difference between RA and LA refractory period was not altered
during remodeling.''' On the other hand. Nattel et al. showed that enhanced vulnerabili-
ty due to rapid atrial pacing was due to an increase in refractoriness heterogeneity.' Also
in patients with atrial fibrillation, the increase in atrial vulnerability is often ascribed to
an increase in dispersion in atrial refractoriness or a widening of the zone of conduction
delay of premature beats.-' •'"
In the present study we showed that enhanced atrial vulnerability might be due to short-
ening of AERP alone. Due to AF-induced shortening of AERP. critical conduction result-
ed more readily in reentry (uni-directional block). These findings imply that already in
normal human atria (no ageing, no remodeling. ...). due to functional properties of the
atrial tissue, a marked substrate for initiation of AF may already exist. However, this
substrate of initiation may remain ronr?«/«/ until either shortening of atrial refractori-
ness (metabolic changes, dilatation. ...) or additional changes in the substrate (cardiac-
disease, tlbrosis, ...) will result in reentry and initiation of AF.
LIMITATIONS
In the present study, atrial vulnerability and the substrate for reentry were measured by
applying external extrastinuili during sinus rhythm. Since in the goat, spontaneous atri-
al premature beats are virtually absent, we could not study the effect of remodeling on
the initiation of AF by spontaneous ectopic beats. Also we do not know whether the
substrate for initiation of AF would be the same after AF of >48hours of duration. During
chronic AI- other changes (like a decrease of connexin 40. an increase in size of the
atrial myocytes. loss of sarcomcrcs. dedilTerentiation. atrial dilatation etc.) might alter
the substrate for initiation of AF.
The limited epicanlial mapping, does not allow complete reconstruction of all the com-
plex interactions between ectopic premature beats and the different pacing modes to
prevent initiation of AF. Since no endocardia! recordings were made, the three-dimen-
sionul structure of the atrial wall, which might play a role in the activation during AF,
was not taken into account.
Table l. Window of Inducibility of AF by Single Premature Stimuli.
Pacing
Sites
RAI
RA2
BBR
BBM
BBL
LA:
LAI
CONTROL
LLI-AF
(ms)
13O±14
I46±18
I48±18
NoAF
136±24
I4O±14
138±I8
(NO REMODELING)
ULI-AF
(ms)
15I±4
152+11
147±16
NoAF
I41±15
140+6
143±I8
WI-AF
(ms)
20±14
10+13
4±7
-
10±2l
4+10
8+15
AFTER 2 4 H OF
LLI-AF
(ms)
97±llt
107+1 Si-
ll 2±19t
NoAF
ll l±23t
IO8±I2+
104+12+
ULI-AF
(ms)
145±14
144±16
145±15
NoAF
144+19
I47±13
146+20
AF
WI-AF
(ms)
45±9+
39±16+
31 ±20+
-
32±25t
52±4O+
41±18+
AFTER 48H OF
LLI-AF
(ms)
74±14+
83±I7+
85±16+
NoAF
98±33+
84±I5+
83±11+
ULI-AF
(ms)
15I±7
!58±2O
15I±11
NoAF
I39+.16
I43±18
145±I9
AF
WI-AF
(ms)
73±l5t
76±22+
66+.13+
-
43±24t
59±16t
62±15t
Mean values (+SD) for d goats: LLI-AF: lower limit of inducibility of AF; ULI-AF: upper limit of inducibility of AF; WI-AF:
window of inducibility of AF: + : p<0.01 compared to control.
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Abstract
Background: Recent studies with the impluntable atrial cardioverter have shown that in
about 277r of the cases AF recurs almost immediately after successful cardioversion. In
the present study we determined the elcctrophysiological properties of the caprine
atrium immediately after spontaneous termination of AF both before and after 48h
of AF-induced electrical remodeling.
Methods: In X goats, atrial effective refractory period (AERP). intra-atrial conduction
velocity (CV) and atrial wavelength (WL) were measured during sinus rhythm, both
before (1=0) and after 48 hours (t=48) of electrically maintained AF (baseline). After
baseline, a 5-min paroxysm of AF was induced during which refractory period (RP*,.)
was determined. AF.RP. CV and WL were also measured immediately after spontaneous
restoration of sinus rhythm (post-AF values).
Results: Both in normal and remodeled atria, immediately after AF. AERP and CV were
markedly decreased compared to baseline (p<0.01). In normal atria. post-AF AERP
(I()7±l4ms) gradually prolonged from its AF-value (I14±17ms) to its baseline value
(r.tx±f.*ms). CV decreased from U()±9cm/s to 117±4 cni/s. After 48 hours of AF, AERP
had shortened to 74±8ms. RPAF was 8y±9ms. Surprisingly, immediately after termina-
tion of AF. AERP was further shortened to 58±6ms (p<().()l). Post-AF CV decreased
from 13o± 11 cni/s to 122± I Ocm/s (p<().() 1). As a result, the post-AF WL became as short
as 7.1 ± 1cm. These changes were transient and all parameters gradually returned to base-
line within 1-2 minutes alter conversion of AF.
Conclusions: Due to a combined decrease in AERP and CV, a marked shortening of the
atrial wavelength occurs during the first minutes after conversion of AF. In electrically
remodeled atria, this results in a transient ultra-short value of AERP (<60ms) and atrial
wavelength (WL:7.1cm). These observations imply a highly vulnerable substrate for
reentry immediately after termination of atrial fibrillation. During this supervulnerablc
phase, both early and later premature beats re-initiated immediate recurrences of AF.
Key Words: Electrophysiology-Atrium-Atrial fibrillation.
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Introduction
Clinical studies with Ihe implantable atrial defibrillator have reported a high incidence
of immediate recurrences of AF (IRAK) within I minute after successful electrical
cardioversion (27<£).'' Mapping of immediate recurrence demonstrated that all IRAF's
were triggered by premature ectopic beats, mostly originating from atrial loci in the
pulmonary veins or crista terminalis." Also after spontaneous restoration of sinus
rhythm, a high incidence of immediate AF recurrences has been reported." Immediate
recurrences of AF after electrical or spontaneous cardioversion of AF may be due to
increased atrial ectopy during the first minutes of sinus rhythm and/or to a higher
vulnerability for the /n;7/<ift'r>;i of reentry.
It is not clear to what extent AF-induced electrical remodeling plays a role in the occur-
rence of IRAF. A progressive shortening of the atrial action potential and refractory period
during the first 1-2 days of AF has been shown to increase both inducibility and persist-
ence of AF. An additional post-cardioversion shortening of atrial refractoriness and slow-
ing of conduction may further enhance the vulnerability of the atria. The aim of the pres-
ent study was to evaluate the electrophysiological substrate lor reentry during the fust 5
minutes after spontaneous termination of AF. both in remodeled and non-remodeled atria.
Methods
Eight goats weighing between 40 and 58 kg (50±6) were used for this study. The study
was approved by the ethical committee of the university of Maastricht and animal han-
dling was carried out according to the European Directive for animal research. Alter
sedation with Nesdonal (15mg/kg I.V.) the animals were anaesthetized by halothane
(I-2*7f) and a mixture of O, and N.O. The chest was opened through a left intercostal tho-
racotomy and three teflon-felt plaque electrodes were sutured to the atria (FigI). Two
oval-shaped plaques (3.5 x 2.5 cm. 30 electrodes, inter-electrode distance 4 mm) were
sutured to the free walls of the right (RA) and left atrium (LA). A strip of 6 x I cm,
containing 23 electrodes (inter-electrode distance 6-10 mm) was pulled through the
space between the aortic root and Bachmanns bundle and sutured to the lips of the
atrial appendages. A small plaque containing 4 electrodes was sutured to the free wall of
the left ventricle (LV). A silver plate was implanted under the skin of the thorax to serve
as indifferent electrode. The electrode leads were tunnelled subcutaneously to the neck
and exteriorized by three 30-pin connectors (Lemosa®). Post-operalively the animals
received buprenorfine (Temgesic®) for 1-3 days. Ampicillinc (l(XK)mg) was given
prophylaclically both before and after surgery.
6o Chapter 4
ICV
SR 50 Hz
PAF (5min) Sinus Rhythm
/•Vv«n' / /^N'ri/i.-iii/on »/ //if r/m>mca//v wnp/art/«/ r/nran/ui/ Wrrf/nrf« (!</>/><•'• /xin<7) 7»<>
<>i<// /)/I|(/MC>. rm/i I'linhimi/ije .W i7r< mx/o. »rrp .vurnrrt/ r« r/ii/rrr IKI// «/ 'l/ii- K/l i/ni/ M.
f Jiir Wn)> ivi'f/i 2.< WITW«/«".! »IM /«»WIIKHCI/ «11 Auc/i/mimi s /»n;ii//i'. /n f/ic /rntrr/iuiiW i/i</iim-
(Kiii <I/'(AI' /i/>/i7/iilinii /XK r»i<iiir 11 iV/u.v/mm/. /Vi wxm <n II/IKI r/m/im i\ </<•!<'( /<•</. « / .wem/
h n i o/'.t/imii/i l i" / / : » »<i.v i/Wiirn-iy /» im/uir AA: «B ffm-Amn/in i />i«i<//c. K.A: ri'v*» <i/rium,-
/^. /<•/( iiliiiim. /'V: />M/»i(»uirv »ri/i.v, .Vf V. .wi/icrior <-<iru/ rci«, /('V. in/cn'or i in 11/1 cm, /MA":
/wmn V.WHII/ 11/f 111/
DATA ACQUISITION
After the goats recovered from surgery (2-3 weeks) they were connected to a data acqui-
sition system recording all unipolar atrial electrograms simultaneously (gain 3(K): band-
width I -5(M) M/). Atrial conduction velocity was measured during sinus rhythm from the
conduction time between two electrodes on Bachmanns bundle (inter-electrode distance
4-6.6cm). Local activation times were determined by a custom made algorithm for
automatic detection of the intrinsic negative deflection of the electrogram. The maximal
negative slope of the unipolar electrogram was taken as the local activation time.
Uniform propagation along Bachmunn's bundle was verified by mapping. It was defined
as homogeneous propagation with synchronous activation of the two rows of electrodes.
Atrial fibrillation cycle length (AFCL) was determined from a unipolar atrial electro-
gram from the right or left atrium by an algorithm detecting the maximal negative slope
of the fibrillation electrogram. The median and 5'" percentile of the AFCL were calcu-
lated from I (X) consecutive AF cycles.
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ELECTRICAL STIMULATION
A pair of electrodes in the center of the electrode-array at ihe free wall of the right (n=5)
or left atrium <n=3) was used for stimulation. Biphusic stimuli of 2ms duration were
applied by a constant current stimulator (Medtronic SP3111). equipped with an amplifi-
er recording a bipolar electrogram from the pacing electriKles. The stimulation threshold
imAl was determined during slow pacing. Atrial fibrillation was maintained by a fibril-
lation pacemaker delivering a I-second burst of stimuli (50 H A 4xdiaslolic threshold) as
soon as sinus rhythm recurred." The atrial effective refractory period (AERP) was
determined during sinus rhythm, during incremental pacing and during regional entrain-
ment of AF. During sinus rhythm, the premature stimuli were synchronized to the bipo-
lar electrogram recorded from the pacing electrodes. After 8 sinus beats, a single stimu-
lus (4xihreshold) was delivered and the coupling interval was incremented in steps of
2ms. The shortest coupling interval resulting in a propagated early response 4mm from
(he pacing site was taken as the AERP. During incremental pacing (SI-SI: 4(M)-lo0ms)
ihe AERP was determined by interpolated premature stimuli (4xthreshold). Starling well
within the refractory period, after every 8'" basic stimulus, the coupling interval was
incremented in steps of 2ms. The shortest SI-S2 interval resulting in a propagated
response was taken as the AFRP. The refractory period during AF <RI\,) was measured
during regional entrainment of AF, as recently described.* The right or left atrium was
paced with an interval equal to the median AFCL (4xdiastolic threshold). Capture during
AF could be differentiated from fihrillatory activity by the latency and morphology of an
electrogram recorded 4mm from the pacing site. In case of capture, the eleclrograms
show a constant morphology (low amplitude S-wave) together with a short and constant
interval between stimulus and response. In addition, mapping was used to verily a radial
spread of activation from Ihe pacing site. After 8 entrained beats, a single premature stim-
ulus was applied with a coupling interval starting well within the refractory period. The
S1-S2 interval was changed in steps of 2ms. In case of capture, the premature electro-
gram showed a similar morphology and latency as during entrainment. The longest S l -
S2 interval that failed to capture the atria was taken as the KP during enlrainmcnt of A F '
Atrial vulnerability was measured by the incidence of AF during measurement of the
AERP. In electrically remodeled atria (l(X)9f induction of AF). the tv/m/ttw of inducibil-
ity (WI-AF) was used to quantify the vulnerability of the atria. The lower limit of the
WI-AF was given by the AERP at the site of pacing, whereas the upper limit of inducibil-
ity was determined by the longest S1-S2 interval still inducing AF.
EXPERIMENTAL PROTOCOL
In each animal, the same protocol was executed twice, once before and once after elec-
trical remodeling (48 hours of AF). Both in non-remodeled and remodeled atria, first a
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baseline study was performed to determine the AERP and conduction velocity during
steady-state sinus rhythm and the rate adaptation of the AERP during incremental
pacing. In case of electrical remodeling, these measurements were performed at least 10
minutes after a 48 hours period of AF maintained by a fibrillation pacemaker. After the
baseline study, a paroxysm of 5 minutes of AF was induced during which the AFCL and
RP*,. were determined. In normal atria, switching off the fibrillation pacemaker resulted
in prompt restoration of sinus rhythm (13±14 seconds, range:4-46). In electrically
remodeled atria, AF persisted some what longer ( I I9± I27 seconds, range:54-320)
before sinus rhythm resumed.
Immediately after spontaneous termination of AF, we determined the time course of
changes in C'V and AF.RP during the first 5 minutes of sinus rhythm (post-AF values).
After restoration of sinus rhythm, C'V was measured continuously from the conduction
times along Bachmann's bundle. The change in AERP was measured 10 times during the
first 5 minutes of sinus rhythm. Single extrastimuli were introduced starting with a cou-
pling interval slightly shorter than the expected refractory period and incremented after
every 4 sinus beats in steps of 2ms. For statistical analysis the exact moments of meas-
urement of the AERP were divided in 5 classes: lOsec (range 0-20); 30sec (range 20-40):
I min (range 40-1:20): 2min (range 1:2O-2:4O): 5min (4-6min). If during measurement of
the post-AF AKKP AF of >8 sec was induced, the measurements were interrupted and
the heart was kept in sinus rhythm for 10 minutes. During this period the AERP returned
to its baseline sinus rhythm value. Then, a new paroxysm of AF (5 minutes) was induced
and measurement of the post-AF AFRP was continued. For each experiment, about 3 to
5 paroxysms were needed to collect at least 10 data points during the first 5 minutes after
a paroxysm of AF. No cumulative effect of repetitive AF inductions on AERP was
observed.
STATISTICAL ANALYSIS
Data are presented as mean ± SD. Statistical analysis was performed by the paired
Student's t-test. A p-value of less than 0.05 was considered as statistically significant.
Results
In Fig 2 the r:\te adaptation of the atrial refractor.' period before and after 48 hours of AF
is plotted for all goats. In normal atria, the AFRP during baseline sinus rhythm was
I38±l3ms. Due to the physiological rate adaptation the refractory period shortened to
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I28±8ms during rapid pacing (p<0.05. SI-SI: 180ms). During entniinment of AF (SI-
SI :l45±12ms) the AERP was 114±l7ms (-17%. p<().() 1. Table I). After 48 hours of AF-
induced electrical remodeling, the AERP during sinus rhythm was shortened to 74±8ms
and the physiological rate adaptation was lost. Since in some goats an inversed rate adap-
tation was present, the average AF.RP slightly prolonged from 74±12ms during slow
pacing (400ms) to 84±l2ms during rapid pacing (p<0.05. SI-SI :170ms). During
entrapment of AF (Sl-SI:IO8±IOms) the AERP was 89±9ms (+21%. p<0.01. Table I).
There were no differences between RA and LA.
AERP Normal
(ms) Atria
140 , i
AF i °120 ^
loo AF After 48 h
• 1 of AF
80 I
60 T T T
100 200 300 4(K) SR
Pacing Interval (ms)
ciifminm«-»!/ o / ^ f HVI.I /<»ij?cr fAun t/i/r/nj; v/nu.i r/i.vfA/n. A/iW. ulria/ <'j(/f<7/ir rr/rui7»ry
.Vff: .nniu ra/f. /4AV fnfrainmcnr »/«/™//7/)rr7/u/iVwi.
ATRIAL WAVELENGTH IMMEDIATELY AFTER CONVERSION OF ATRIAL
FIBRILLATION
Both in normal and remodeled atria, atrial refractoriness was transiently shortened
immediately after termination of AF. A representative example is given in Fig 3. In the
absence of electrical remodeling, immediately after termination of AF. AERP during
sinus rhythm gradually prolonged from iLs AF value (124ms) to baseline (155ms). In
electrically remodeled atria, the AERP during baseline sinus rhythm (at least 10 minutes
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Normal Atria
(No Remodeling)
After 48h of AF
(Electrical Remodeling)
Baseline SR Baseline SR
A F (Enlrainmcnl: 150ms)
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A F (Enlrainment: 108ms)
Post-AF SR Post-AF SR
120 55
I4()
/ »»««/<•
Ml
c —f^—-—yrvvvVvT'
150, 75
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arter spontaneous cardioversion of a 48-hours period of AF) was as short as 76ms. During
entrainmcnt of AI-. the refractory period was 86ms. Immediately after termination of a
new paroxysm of AF (.Smin). (he AERP was extremely shortened to a value of 56ms. Also
intra-atrial conduction was temporarily depressed immediately after termination of AF. A
representative example is shown in Fig 4. Both in normal and remodeled atria, the con-
duction \elocily of (he tust sinus beats after termination of a 5min paroxysm of AF was
significantly decreased (110 and I I6cm/s respectively). Normal atrial conduction veloci-
ty wus restored rapidly within one minute of sinus rhythm (not shown).
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In Fig 5 and Table 1 the AERP. CV and WL arc given for all goals (n=8). Whereas in
normal atria the AERP shortened from 138± 13ms during sinus rhythm to 114± 17ms dur-
ing AF. in remodeled atria (48h of AF) the AERP actually slightly prolonged from
74±8ms to 89±9ms. After restoration of sinus rhythm, in normal atria the AERP gradu-
ally prolonged from its AF value to the baseline value during sinus rhythm. In contrast,
after 48 hours of electrical remodeling, immediately after cardioversion of AF the AERP
shortened markedly from 89±9ms during AF to 58±6ms after 10 seconds of sinus
rhythm. As a result, after termination of a 5-niin paroxysm of AF. the AERP was respec-
tively 22 and 21% shorter than during baseline sinus rhythm (p<0.()l). Both in remod-
eled and non-remodeled atria, this posl-AF shortening of the AERP lasted only for a few
minutes and after 5 minutes of sinus rhythm the AERP had already returned to ils huse-
line value. Atrial conduction velocity directly after termination of AI- was slightly
decreased (-10%. rxO.Ol) both in normal and remodeled atria. Normal atrial conduction
velocity was restored within 2 minutes of sinus rhythm (p=0.32 and p=(). 13). Due to the
posl-AF changes in AERP and CV. immediately after cardioversion the alrial wavelength
was shortened by respectively 30% and 29% (p<().()l). Due lo the combination of elec-
trical remodeling and the immediate post-AF" changes in AERP and CV, alter conversion
of 48 hours of AF the atrial wavelength became temporarily as short as 7. l± lcm.
Compared to a wavelength of 17.7cm in normal atria, immediately after cardioversion of
AF the WL in remodeled atria was shortened by more than 607r. These immediale posl-
AF changes were not associated with alterations in sinus rale. Three lo five sinus heals
after cardioversion. sinus rate was equal to the rale before the paroxysm of AF.
VULNERABILITY TO ATRIAL FIBRILLATION IMMEDIATELY AFTER
TERMINATION OF AF
Both in normal and remodeled atria, the vulnerability for initiation of AF was higher
immediately after termination of AF. In normal atria a single early premature beat
evoked a short paroxysm of AF in only 2 of 8 goats. Immediately after a 5-min parox-
ysm of AF, an early premature beat reinduced AF in 7 of 8 goats. In electrically remod-
eled atria, already during baseline, AF was induced in 8/8 goats (Table I). To assess the
difference in post-cardioversion vulnerability, the window of inducibility by single pre-
mature beats was determined within 30 seconds after termination of AF. An example is
shown in Fig 6. Immediately after termination of AF the window of inducibility was
widened from 74 to 94ms. In Table 2 the data are given for all 8 goats. In remodeled atria
(48h of AF) the window of inducibility was 90±15ms (lower limit:74±8ms; upper
limit: 167± I Ims). Immediately after spontaneous conversion of Smin of AF, the window
of inducibility was increased by 20% to 109±22ms (p<0.05). This was due lo shortening
of the refractory period from 74±8ms to 57±IOms (p<0.0l) without a concomitant
change in the latest premature beat that induced AF ( I68±I9 versus I67±l I. p=0.8).
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CHARACTERISTICS OF IMMEDIATE RECURRENCES OF ATRIAL
FIBRILLATION (IRAF)
To study the effects of the transient shortening of the atrial refractory period after termi-
nation of AF in remodeled atria, we analyzed the AFCL during the first phase of imme-
diate recurrences of AK In Fig 7 an example is gi%en of an immediate reinitiation of AF.
4 seconds alter spontaneous termination of a 5min episode of AF. A single premature
stimulus was applied with a coupling interval as short as 46ms. This very early prema-
ture stimulus restarted AF. Interestingly, at the beginning of IRAF. the AF cycle length
was markedly shortened (65ms) to prolong again during the first 5-6 seconds of the
recurrence of AF.
In the 8 remodeled atria (48h of AF) the median AFCL during the 5-min paroxysms of
AF was 107±^ms (5* percentile:9()±l2ms). The AFRP measured during entrainment of
AF was 89±')ms. Immediately after termination of AF (5±3sec). the AFRP during sinus
rhythm was as short as 57±10ms (-369K p<0.0l). Also, the AFCL during the first sec-
ond of IRAF was significantly shorter (66±6ms. p<().01). However, already after 6 sec-
onds. AFCL had returned to its baseline value (104±23ms. p=0.46). This observation
strongly supports the transient shortening of the alrial refractor) period immediately
after termination of AF.
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Discussion
IMMEDIATE RECURRENCE OF AF
Immediate recurrences of AF can occur both after internal (27*7r) and external (26%)
electrical defibrillalion.' '•" " The time between successful cardioversion and immediate
recurrence varies between 8±5 seconds (range 2-20) and 16±17 seconds (range 2-55)."
All IRAF's arc triggered by premature ectopic beats, the coupling interval ranging
between 310 and 580ms (418±79). Ectopic beats with a coupling interval longer than
6(K)ms never lead to recurrence of AF. Immediate recurrences of AF may be caused by
an increase in / r /^ ' t rv (enhanced alrial ectopy) or a vulnerable substrate for i/t/r/anVm of
reentry during the first minutes of sinus rhythm after cardioversion.
A SUPERVULNERABLE SUBSTRATE FOR REENTRY IMMEDIATELY
AFTER TERMINATION OF AF
In the present study we evaluated the electrophysiological substrate immediately after
termination of AF in the caprine model. The main findings were the following: ( I )
During the first minutes alter spontaneous termination of AF. both in normal and remod-
eled atria, a transient shortening of atrial refractoriness occurred. (2) These changes were
associated with a transient depression of atrial conduction velocity, resulting in a marked
temporal shortening of the alrial wavelength directly after termination of AF. (3) In
remodeled atria, due to the cumulative effects of AF-induced electrical remodeling and
immediate post-cardiovcrsion changes, the AERP and wavelength could become as short
as 58ms ami 7.1cm respectively. (4) In remodeled atria, during the first minute of sinus
rhythm, the window of inducibility of AF by single premature beats was markedly
widened.
These observations imply that directly after termination of atrial fibrillation a highly
vulnerable substrate for initiation of reentry exists.'"'' Especially after cardioversion of
AF lasting longer than 24 hours, the cumulative effects of electrical remodeling and the
immediate post-AF changes will result in a "supervulnerable phase" during the first
minutes of sinus rhythm. During this supervulnerable phase, both early and later prema-
lua' beats can be expected to initiate immediate recurrences of AF.
However for immediate re-initiation of AF. the spontaneous occurrence of atrial triggers
is at least as important as a vulnerable substrate for reentry. This is illustrated by the fact
that due to the absence of atrial ectopy, in our goat model not a single case of sponta-
neous IRAF was observed.
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ATRIAL REFRACTORINESS
It is already known for a long time that the refractory period adapts to acute changes in
cycle length." ' Both experimental and clinical studies have shown that at increasing
heart rates the atrial refractory period becomes progressively shortened (physiological
rate adaptation).*"•""' Although the duration of the refractory period is predominantly
determined by the preceding cycle length. '" after a marked change in heart rate, it may
lake up to several hundred beats before a new steady-state has been reached. ' ' As in
the studies by Daoud et al. " and Yu et al.. •" we observed that in normal alria. alter car-
dioversion of AF it takes about 5 minutes for the refractory period to adapt to the slow-
er sinus rhythm. The duration of the atrial refractory period is largely determined by the
duration of the plateau phase of the action potential, carried predominantly by I he cal-
cium current. Calcium overload, resulting from the high rate during AI-, causes inacti-
vation of the L-type calcium channels (calcium-induced inactivation) which, in combi-
nation with the decreased gradient of Ca". will reduce the magnitude and duration of
calcium inflow and shorten the plateau phase of the action potential.'" Alter conver-
sion to sinus rhythm, it may take several minutes for the Na/Ca exchanger and (lie ATP-
driven active Ca" transport to lower the cytoplasmic Ca" concentration. The gradual
reduction of the calcium-induced inactivatinn of calcium-current will result in a
progressive prolongation of the action potential.
The observed acute post-cardioversion shortening of atrial refractoriness in electrically
remodeled atria was quite unexpected. As shown by several studies, '••""' the physio-
logical rate adaptation of the atrial refractory period is lost after long-lasting AF due to
a reduction of the L-type calcium current." " In the presence of a flat rale adaptation
curve we expected no effect anymore of changes in heart rate on the atrial refractory
period. At this moment one can only speculate about the mechanisms underlying the
transient shortening of the action potential after cardioversion of remodeled atria.
Changes in neurohumoral balance do not seem to play a major role since sinus rate aller
cardioversion was equal to the rate before the paroxysm of AF. During a sudden change
in heart rate various metabolic alterations occur like changes in inlra-and extracellular
ion concentrations, ion pump activity, phosphorylation of ion channels, intracellulur
acidosis. etc." " It is yet unclear whether the increase in mc/a/w/ic- demand during AF
may lead to atrial ischemia."
ATRIAL CONDUCTION VELOCITY
Although it is well known that at high heart rates atrial conduction velocity is
decreased. '*•"• * the present study is the first to measure atrial conduction velocity after
transition from AF to sinus rhythm. Immediately after termination of AF conduction
velocity was K M slower than during normal sinus rhythm. After cardioversion atrial
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conduction velocity was restored quickly within 1-2 minutes. The slowing of atria! con-
duction after AF is probably due to an increase in intracellular sodium and extracellu-
lar potassium concentration due to the high atrial rate during A F . ' " The associated
decrease in membrane resting potential and driving force for sodium ions wil l lower the
upstroke velocity of the atrial action potential and consequently lower the conduction
velocity of the first sinus beats. In addition, a high intracellular Ca" concentration after
conversion of AF may lead to a decrease in electrical coupling of the atrial myocardi-
um and a slowing of conduction of the atrial impulse." It may take 1-2 minutes before
Ihc normal intraccllular sodium and calcium concentrations arc restored and a new
metabolic steady-state is reached.
POSSIBLE CLINICAL RELEVANCE
In previous studies in the goal we measured .vf«j</y-.v/«/p changes in atrial refractoriness
induced by prolonged episodes of maintained AF.' It was found that atrial fibrillation
itself induced a progressive shortening of the atrial refractory period from about 140 to
less than 80ms (electrical remodeling). This shortening of the action potential has been
shown to be due to a down regulation of the L-type calcium current (altered gene expres-
sion)." " In the present study the rran.v;>nr changes were studied occurring immediately
aller termination of AF. During the first minutes of sinus rhythm an additional shorten-
ing of atrial refractoriness occurred, resulting in a refractory period transiently shorter
than 50ms. The transient post cardioversion shortening of refractoriness should not be
confused with AF-induced electrical remodeling." This is clearly illustrated by the
markedly different time course of recovery of the immediate post-AF shortening (min-
utes) compared to electrical remodeling (days)."
Recurrence of atrial fibrillation during the first days after electrical cardioversion has
been ascribed to fibrillation-induced electrical remodeling of the atria."' The high inci-
dence of /W»K'</I<//<' recurrences of AF (during the first minutes) can be explained by the
additional transient shortening of RP described in the present study (supervulnerable
phase). On the other hand, together with electrical remodeling, the supervulnerable
phase may also play an important role in the persistence of AF. In patients w ith chronic
AF'. it has been shown that AF' still terminates spontaneously but that AF recurs within
seconds (immediate re-initiation)."
It still has to be shown whether prevention of post-AF shortening of refractoriness by
antiarrliNthmic drugs might reduce the incidence of immediate and early recurrences."
On the other hand, the postcardioversion shortening of atrial refractoriness might also be
prevented by preventing the sudden change in atrial rate after cardioversion of AF.
Deeremental rapid post-AF pacing might prevent the incidence of IRAF. not only by
overdrive suppression of atrial ectopy, but also by preventing the immediate post-AF
shortening of ALRP.
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LIMITATIONS
In the present study, the supervulnerable phase was evaluated after .V/MIN/«HCOM.V termi-
nation of AF. In case of direct-current cardioversion the electrical shock may cause tran-
sient electrophysiological changes. Thus, after electrical cardioversion. the substrate for
reentry and the vulnerable phase may be different than after spontaneous cardioversion
of AF. Also we do not know whether the supervulnerable phase would be the same after
AF of >48hours of duration. During chronic AF other changes (like a decrease of
connexin 40. an increase in size of the atrial myocytes, loss of sarcomeres. dedifferenli-
alion. atrial dilatation etc.) might alter the immediate post- AF vulnerability. Another lim-
itation is that we could not study the incidence of spontaneous 1RAF since the goat did
not show any atrial ectopy. Because of this our study does not provide information about
the important question whether immediately after cardioversion atrial triggers might
occur more frequently or whether atrial ectopic beats arc more premature.
Table 1. Atrial Electrophysiology Immediately After Termination of AF.
Time
Baseline
Rapid Pacing
AF
Post-AF
KKec
30sec
Imin
2min
Smin
Normal
138±13
I28±8
U4±17
IO7±14
II9±I7
125+.I6
13I±I5
135±14
AERP
(MS)
A%
-7%±
-17%+
-22%t
-14%+
-10%+
-5%±
-2%
48h
AF
74±8
84±I2
89±9
58±6
62±6
65±7
69±7
72±8
A *
+ 14%±
+21%+
-21%+
-16%+
-12%+
-6%±
-3%
Normal
13O±9
-
U7±9
123±1()
126±9
129±9
13O±9
CV
(CM/S)
A% 48h
AF
136±11
-
-10%+ 122±10
-6%+ 126±IO
-4%± 129±9
- 1 % 134±l()
0% 136±11
A%
-
-10%+
-7%+
-5%±
- 1 %
0%
Normal
17.7±1
-
12.4±l
14.2±2
15.5±2
16.6±2
17.0+2
WL
(CM)
A% 48h
AF
10.0±l
-
-30%+ 7.1 + 1
-19%+ 7.8±1
-12%+ 8.4±1
-6%± 9.2±1
-2% 9.7±l
A%
-
-29%+
-22%t
-16%+
-8%±
-3%
INDUCIBILITY
Norma
2/8
-
7/8
5/8
3/8
2/8
2/8
48h
AF
8/8
-
8/8
8/8
8/8
8/8
8/8
Mean values (±SD) for 8 goats: AERP. atrial effective refractory period: CV. conduction velocity: WL. wavelength: ± p<0.()5. + p<0.()l
Table 2. Atrial Vulnerability immediately after Conversion of AF.
Baseline
Post-AF
A9r
AFTER 48 HOURS OF AF (REMODELING)
WI-AF (ms)
9O±15
109±22
+20%
(p<0.05)
LLI-AF (ms)
74±12
57±10
-23%
(p<0.0l)
ULI-AF (ms)
I67±ll
168±19
1%
(n.s.)
WI-AF: window of inducibility of AF: LLI-AF: lower limit of inducibility of AF: ULI-AF: upper limit of inducibility of AF
I
Z
m
3«
I
V «
o
>
76 I Chapter 4
References
1. Wellens HJJ. Lau CP, Luderitz B. Akhtar M. Waldo AL, Camm AJ. Timmermans C, Tse HF. Jung
W, Jordaens L. Ayers G, for the METRIX Investigators. Atrioverter: an implantable device for the
treatment of atrial nhrilhition. O><H/<»IV>«. 1998:98: 1651 -1656.
2. Timmermans C. Rodriguez LM. Smeets JLRM, Wellens HJJ. Immediate reinitiation of atrial
fibrillation following internal atrial defibrillation. 7 Canr//(na.vc ßpi/mp/im»/, 1998: 9:122-128.
3. Sra J. Biehl M. Blanck Z. Dhala A, Jazayen MR. Deshpande S. Akhtar M. Spontaneous
reinitiation of atrial fibrillation following transvenous atrial dcfihrillation. /MC£,
1998:21:1105-1110.
4. l.au (P. Tsc HF. Aycrs GM. Defihrillalion-guided radiofrequency ablation of atrial fibrillation
secondary to an alrial focus. 7 Am C7>// Ow/iV»/. 1999:33:1217-1226.
5. Haissugucrre M. Jais P. Shah IX". Arentz T. Kaluschc D. Takahashi A. Garrigue S. Hocini M. Peng
J l . C'lcmenty J. Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers.
7 Om//V«'«.vc /• / f r tmpkiw/, 2000:11(1 ):2-l<).
6. Hoffmann H, Janko S. Steinbeck G. Kdvardsson N. Camm J. for the AFT study group. Onset
scenarios of paroxysmal alrial fibrillation using new diagnostic pacemaker functions (abstract).
«4C7-.. 2(XX). 23(partll);656.
7. Wijffcls MCF.F. Kirchoft C'JHJ. Dorland R. Allessie MA. Atrial fibrillation begets atrial fibrillation:
u sliuly in awake chronically instrumented goats. Onu/iii/n/i, 1995:92:1954-1968.
8. Gamut C'J. Duylschaever M. Killian M. Dorland R. Mast K Allessie MA. Repetitive electrical
remodeling by paroxysms of atrial fibrillation in the goat: no cumulative effect on inducibility or
stability of alrial fibrillation. 7 Om/iVnmc fc7«-m»/>*v.w«/. 1999:10:1101 -1108.
9. Duytschaever M. Mast I', Killian M. Blaauw Y. Wi jffels M. Allessie MA. Methods for determining
the refractory period und excitable gap during persistent alrial fibrillation in the goat. O/ru/uno/i.
2001:104:957-962.
10. Wiener N, Rosenblucth A. The mathematical formulation of the problem of conduction of
impulses in a network of connected excitable elements, specifically in cardiac muscle. A/r/i /n.«
(Vm/i../ Mi-.v 1946:16:205-265.
I I Baker BM. Botleron GW, Smith JM. Low-energy internal cardioversion for alrial fibrillation
resistant to external cardio\ersion../ ('<;n//<»<i.vc £7<"<7n>/>/iv.v/7>/, 1995:6:44-47.
12. Schmitt C, All h. Plewan A. Ammer R. Leibig M. Karch M. Schomig A. Low energy intracardiac
eardioversion after failed conventional external cardioversion of alrial fibrillation. 7 Am G>//
(Wi<>/. 1996:28:994-999
13. Saksena S. Prakash A. Atrial defibrillalion: Techniques and clinical results. In Saksena S. Luderitz
B. eds. //mnrmii imi/ £/«rm>/>/iv.w«>/i>£v:/l 7<'.\f/>»xwt. Second edition. Futura Publishing Company,
Annonk NY. 1996. pp.509-520.
14. Bianconi L. Mennuni M. l.ukic V. Castro A. ChiefTi M. Santini M. Effects of oral propafenone
administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled
study../ \m ("..// (Vin/iW. 1996:28:7(X>-706.
15 Yu WC. Lin YK. Tai CT. Tsai CF. Hsieh MH. Chen CC. Hsu TL. Ding YA. Chang MS. Chen SA.
THE SUPERVUINERABIE PHASE AFTER TERMINATION Of AF I 7 7
Early recurrence of atrial ribrillation after external cardioversion. /MCE. I999;22:1614-1619.
16. Smeels JLRM. Allessie MA. Lammen. WJF.P. Bonke HIM, Hollen SJ The wavelength of the
cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. The role of heart rate,
autonomic transmitters, temperature and potassium. O'/r Ä« . 1986:58:96-108.
17. Rensma PL. Allessie MA. Lammers WJEP. Bonke F1M. Schalij MJ. Length of excitation wave and
susceptibility to reentrant alrial arrhythmias in normal conscious dogs. Cm- ff«'.v. 1988:62:395-410.
18. Daoud KG. Bogun F. Go\al R. Harvey M. Man KC. Slnckherger SA. Morady F. Effect of atrial
fibrillation on atrial refractoriness in humans. Cmu/<i/ir»i. 1996:94: 1600-1606.
19. Mende/ C. Grun/it CC. Moe GK. Influence of cycle length upon refractory period of auricles,
ventricles and AV node in the dog. ,4m 7 /Viv.wo/. 1956; 184:287.
20. Denes P. Delon W. Dhingra R. Pietras RJ. Rosen KM. The effects of cycle length on cardiac
refractory periods in man. Cimi/<irj<»t. 1974:49:32-41.
21. Goodman DJ. Rossen RM. Rider AK. Harrison IX' The effect of cycle length on cardiac
refractory periods in the denervated human heart. ,4m Mr<i/v7. 1976:91:332-338.
22. Janse MJ. Van der Steen. van Dam RT. Dürrer D. Refractory peritKl of the dogs ventriculur
myocardium following sudden changes in frequency. Cm K M , 1969:24:251-262.
23. Carmcliel E. Repolari/ation and frequency in cardiac cells. 7 /Viv.wW (Paris). I977;7.V9O3-92.V
24. Olsson SB. Broman H. Hellstrom C, Talwar KK, Volkmann R. Adaptation of human ulnul muscle
repolari/ation after high rate stimulation. Can/iotw«- /?«. 1984:19:7-14.
25. Yu WC. Chen SA. U c SH. Tai CT. Feng AN. Kuo BIT. Ding YA. Chang M.S. Tachycardia-induced
change of alrial refractory period in humans: rate dependency and effects of anliarrhythmic drugs.
Cmu/uiwn. 1998:97:2331-2337.
26. Li GR. Naltel S. Properties of human atrial /,-, at physiological temperatures and relevance lo
action potential, /tm 7 /'/iv.viV»/. I997;272:H227-H235.
27. Courtemanchc M. Ramirez RJ. Nattel S. Ionic mechanisms underlying human atrial action
potential properties: insights from a mathematical model ,4m 7 /»/i.v.wW. 1998:275:11301-321.
28. Altuel P, Childers RW. Cauchemez B, Poveda J. Mugica J. Coumel P. Failure in the rale adaptation
of the atrial refractory period: its relationship lo vulnerability. / / i / 7 C<mW. 1982:2:179-197.
29. Franz MR. Karasik PL. Li C. Moubarak J. Chavez M. Electrical remodeling of the human atrium:
similar effects in patients with chronic atrial ribrillalion and alrial flutter. 7 4m C«//
O i A I . 1997:30:1785-1792.
30. Yu WC. Tai CT. Tsai CF. Hsieh MH. Chen CC. Ding YA. Chang MS. Chen SA Reversal of alrial
electrical remodeling following cardioversion of long-standing atrial fibrillation in man.
Can/iVna.« /fev. 1999:42:470^76.
31. Yue L. Feng J. Gaspo R. Li GR. Wang Z. Nattel S. Ionic remodeling underlying action potential
changes in a canine model of atrial fibrillation. O n /?«% 1997:81:512-525.
32. Van Wagoner DR. Pond AL. Lamorgese M. Rossie SS. McCarthy PM. Nerbonnc JM. Alrial L-type
Ca'* currents and human atrial fibrillation. O n £ « . 1999:85:428-436.
33. Bosch RF. Zeng X. Grammer JB. Popovic K. Mewis C. Kuhlkamp V. Ionic mechanisms of
electrical remodeling in human alnal fibrillation. C<ja//»r<u<- /?<•.». 1999:44:121-131.
34. Kalz AM. T Wave "memory": possible causal relationship lo stress-induced changes in cardiac ion
channels ? 7 Can/zovYur £/<rrmpAv5io/. 1992:3:150-159.
Chapter 4
35. While CW. Kerber RE, Weiss HR. Marcus ML. The effects of atria! fibrillation on atrial
pressure-volume and flow relationships. O'/r /fas. 1982:51:205-215.
36. Plumb VJ. Karp KB. James TN. Waldo AL. Atrial excitability and conduction during rapid atrial
pacing. Grtu/a//«n, 1981:63:1140-1141.
37. Leislad K, Verbürg E. Christensen G. Cytosolic calcium overload, not atrial ischemia, accounts for
posl-fibrillation alrial dysfunction (abstract). O'n-u/anVm. 1994:90:492.
38. Ruban M. Dowcll J. Ziad I. Zipcs DP. |K | " Accumulation in the acutely fibrillating canine
atrium (abstract). /MCE. I999;22:744.
39. Brcdikis J. Bukauskas F. Veteikis R. Decreased intercellular coupling after prolonged rapid
slimulalion in rabbit alrial muscle. Cm- ftc.v, 1981:49:815-820.
40. Tieleman RG. Van Gelder IC. Crijns HJ. de Kam PJ. van den Berg MP. Haaksma J. Van der Woude
HJ. Allcssie MA. Early recurrences of atrial fibrillation after electrical cardioversion: a result of
fibrillation-induced electrical remodeling of the atria? 7 Am G»// Gin//«/. 1998:31:167-173.
41. Van Noord T. Van Gelder IC. Crijns HJ. Pericardioversion dofetilide does not suppress immediate
and subacule recurrences of persistent atrial fibrillation. (Vnii/fll;wi, 2OOI:1O4:E57.
79
Chapter 5
Is there an Optimal Pacing Site to Prevent
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Abstract
Background: Atrial pacing is able to reduce the number of recurrences of atrial fibrilla-
tion (AF). It is unclear to what extent this effect is determined by the site(s) of pacing.
Methods: In ft electrically remodeled goats (24h AF), the window of inducibility of AF
(WI-AF) was determined by applying premature stimuli (S1-S2) at the right (RA) or left
(LA) atrium (baseline values). Determination of WI-AF at RA and LA was repeated dur-
ing preventive pacing at 4 sites: RA. LA. Bachmanns Bundle (BB) and RA+LA (Bi-atri-
al). Mapping was used to elucidate the mechanisms of prevention of AF.
Results: At baseline. WI-AF was 49±9ms at RA and 45±17ms at LA. Initiation of AF
was associated with conduction block of the premature beat at BB. Preventive pacing at
BB markedly shortened WI-AF at RA (25±1 lms) and LA (I7±8ms. p<0.()l). Pacing at
RA only shortened WI-AF at LA (23±9ms, p<().()l), whereas pacing at LA only short-
ened WI-AF at RA (23±1 lms. p<().()l). Bi-atrial pacing failed to shorten WI-AF both at
RA and LA. Prevention of AF by pacing was due to prolongation of the premature inter-
val at BB.
Conclusions: In the caprine model of AF. Bachmann's Bundle is a critical area of con-
duction ol premature beats and initiation of AF. Pacing at BB can prevent but not com-
pletely abolish the initiation of AF by single premature beats (.v/iorfp/i/ng «/»/if HWKfYw
«/im//«7/>i7/»v). Prevention of AF by pacing is based on prolongation of the premature
interval at BB thus preventing conduction block and reentry. The optimal site for
preventive pacing is close to the area of block and remote from the origin of premature
beats.
Key-words: Fihrillation-Hlectrophysiology-Pacing.
Condensed abstract
In the goat model of atrial fibrillation (AF). we compared the effect of different sites of
preventive atrial pacing on the window of inducibility of AF by right and left atrial
premature beats. Initiation of AF was due to critical conduction of the premature impulse
at Bachmanns bundle. The optimal site of preventive pacing was close to the area of
block and remote from the origin of premature beats. Preventive pacing was based on
pre-excitation of (he critical area of conduction.
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Introduction
Atrial pacing has been shown to reduce the number of paroxysms of AF in patients with
sinus node dysfunction.'' Dauben et al. demonstrated that bi-atrial pacing reduced the
likelihood of atrial flutter and fibrillation in patients with advanced inter-atrial conduc-
tion delay.' Saksena et al. showed that both single-and dual-site pacing of the right atri-
um markedly prolonged the arrhythmia-free interval." Recently, several studies have
shown that after coronary artery surgery the incidence of AF is markedly reduced by atri-
al pacing."' The mechanisms of prevention of AF by atrial pacing are not clear."'"
Especially it is still uncertain to what extent the location and number of pacing sites can
improve the efficacy of prevention."••""
Atrial pacing might prevent AF by inhibiting the fn#j>«'r.v of AF due to prevention of
bradycardia or suppression of atrial premature beats. " In the present study we investi-
gated (he mechanisms by which atrial pacing can attenuate the si//>\//<ifc of initiation of
AF by atrial premature beats. It was found that atrial pacing can reduce the window of
inducibility of AF. The degree of this anti-arrhythmic effect was largely dependent on ilk-
pacing site relative to the site of origin of the premature beat and the area of inlra-alrial
conduction block.
Methods
GOAT MODEL OF ATRIAL FIBRILLATION
Six goats weighing between 40 and 58 kg (48±7) were used for this study. Animal han-
dling was carried out according to the European Directive for animal research. After
sedation with Nesdonal. the animals were anaesthetized by halothane and a mixture of
O. and N,O. Two rectangular plaques (3 x 2.5 cm. 30 electrodes, inter-electrode distance
4 mm) were sutured on the free wall of the RA and LA. A strip of 6 x I cm. containing
23 electrodes (inter-electrode distance 6-10 mm) was pulled through the space between
the aortic root and Bachmann's bundle (BB) and sutured to the tips of the atrial
appendages (Fig.l). The electrode leads were tunneled to the neck and exteriorized by
three 30-pin connectors. After the goats had recovered from surgery (2-3 weeks) they
were connected to a data acquisition system recording all unipolar atrial electrograms
simultaneously (gain 300: bandwidth 1-500 Hz). Local activation times were determined
automatically by an algorithm detecting the maximal negative slope of the electrograms.
Isochrones were drawn manually at 10ms intervals. Atrial pacing was performed using a
stimulator generating biphasic stimuli of 2ms. In the present study. AF was maintained
for 24 hours by a fibrillation pacemaker." '*
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ELECTROPHYSIOLOGICAL MEASUREMENTS
After 24h of AF. programmed electrical stimulation (S1-S2) was performed both at RA
and l.A to determine the window of inducibility of AF (Wl-AF) at baseline (Fig.l).
During regular pacing (SI-Sl:4(K)ms). premature stimuli (SI-S2, 4x threshold) were
interpolated, starting with a coupling interval of 250ms. Each coupling interval was
applied 3 times before it was decremented in steps of 5ms. The upper limit of inducibil-
ity (Ul.l-AF) was determined as the longest coupling interval (S1-S2) inducing AF
(>lsec). whereas the lower limit (LLI-AF) was taken as the shortest S1-S2 interval that
still induced AF. WI-AF was defined as the time window between the longest and short-
est SI-S2 coupling interval inducing AF. The atrial effective refractory period (AERP)
was determined at 5 sites: RA. BB,,^,. BB,„„, BB^and LA. During regular pacing (Sl-
Sl:4(K)ms). premature stimuli (SI-S2. 4 x threshold) were interpolated, starting well
within the expected refractory period. After every 8* basic interval, the coupling interval
was incremented in steps of 2ms. The longest SI-S2 interval that failed to capture the
utrium was taken as AERP.
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In each goat, the effects of different sites of atrial pacing on Wl-AF were determined in
random order. Pacing (SI-SI:400ms) was performed at 4 sites: RA, LA, BB„,, and
RA+LA (Fig.l). During preventive pacing, single premature stimuli were applied at RA
and LA. A stimulator was used which also recorded a bipolar atrial clcctrogram al (he
site of stimulation (Medtronic SP3 III). The degree of prematurity was varied by chang-
ing the coupling interval relative to the preceding bipolar electrogram (AI-S2 interval).
Starting with a coupling interval of 250ms. the AI-S2 interval was decremented in steps
of 5ms. Each interval was repealed 3 times. Wl-AF was defined as the lime window
between the longest and shortest AI-S2 coupling interval inducing AF.
STATISTICAL ANALYSIS
Data are presented as mean ± SD. Statistical analysis was performed by the paired
Student's t test. WI-AF during preventive pacing (A1-S2) was compared to WI-AF at
baseline (S1-S2). A p-value of less than 0.05 was considered as statistically significant.
Results
INITIATION OF AF BY SINGLE PREMATURE BEATS
A representative example of WI-AF after 24h of AF is shown in Fig.2. Due to AF-
induced electrical remodeling. AERP was 94ms. Single premature stimuli with coupling
intervals between 96 and 150ms all induced AF (WI-AF:54ms). In Table I. WI-AF val-
ues at baseline are given for 6 goats. LL1-AF, determined by the AKRP, was l()l±6ms at
RA and 108±10ms at LA. ULI-AF was similar in both atria (I5()±6ms and 152±^ms).
Thus, at baseline WI-AF at RA (SI-S2) was 49±9ms and 45±l7ms at LA. Measurement
of WI-AF was highly reproducible and varied less than <5ms during a time period of 4
hours. All premature coupling intervals in this window invariably induced AF' (no gap).
Initiation of AF by single premature stimuli was found to be associated with critical con-
duction at Bachmann's bundle. In Fig.3. a representative example is given (SI-S2 at
RA: 150ms). Unipolar electrograms recorded at RA. BB,,,*, BB„,„„ BB,,,, and LA are
shown together with activation maps of BB. RA and LA. During regular pacing (SI) the
wavefront propagated uniformly from RA along BB to LA. During the premature beat
(S2), the unipolar electrogram at B B ^ became fragmented and of low amplitude.
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From the activation map it can be seen that BB^, was activated afier a considerable delay
(AI-A2 interval at BB^,,: 197ms). During the first beat ot AF. the earliest activation
occurred at BB,,^ proximal to area of fragmented potentials. The combination of low-
voltage potentials at BB„„j and early re-excitation of BB,,^ strongly suggests that AF was
initiated by block and reentry in Bachmann's bundle. However, the activation maps can
not distinguish between micro-reentry within BB and macro-reentry involving the inter-
amal septum.
ELECTROPHYSIOLOGICAL PROPERTIES OF BACHMANN'S BUNDLE
In all goats, complete conduction curves along BB were determined during SI-S2 stim-
ulation at RA and LA. In Fig.4, the average A1-A2 intervals along BB are given for ft
goats during S1-S2 pacing at RA. At long coupling intervals (SI -S2:25O-1 SOrns).
premature beats conducted normally along BB. However, at SI-S2 intervals <IH()ms. a
progressive conduction delay along BB became apparent (AI-A2„„^„>AI-A2„„„,,„
p<().()5). At coupling intervals shorter than l5K±lftms. the electrogram at BB,,,,,, became
fragmented and of low amplitude and all premature stimuli were associated with
markedly prolonged A1-A2 intervals at BB,,,,(p<O.OI compared to BB,,,,,,). Conduction
delay at RA (prolongation of Al-A2,,,,,,^,) only became apparent at S1-S2 intervals short-
er than 120ms. The events during premature stimulation at LA were almost an exact mir-
ror image of pacing at RA (not shown).
Critical conduction at BB seemed to be due to a longer AFRP at BB ,. In Fig.4 (right
panel) we plotted representative tracings of the shortest SI-S2 intervals at RA. BB,,,,,,.
BB„„j. BB,,.,, and LA resulting in a propagated atriai response. Clearly, at BB„,„, AFRP
was markedly longer than AERP at other sites. For all goats, the average AFRP at BB,,,,,,
was 163115ms. significantly longer (p<().()5) than in the right and left part of BB
(117±14 and I I5±22ms) or RA (l()l±6ms) and LA (.108110ms).
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EFFEa OF PREVENTIVE ATRIAL PACING ON THE WINDOW OF
INDUCIBILITY OF AF
In Fig.5. representative tracings are shown of the effects of preventive pacing on the
inducibility of AF by right and left premature stimuli (AI-S2:l5Oms) Without preven-
tive pacing a premature beat with an SI-S2 interval of I Sums invariably had induced AF.
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During preventive pacing. AF was prevented in 4 specific situations. In case of prema-
ture stimuli at RA. preventive pacing at LA and BB were both effective. During prema-
ture stimulation at LA. in contrast preventive pacing at RA and BB were effective. In
Fig.6. the effects of preventive pacing on WI-AF are given for all goats (n=6). Without
preventive pacing WI-AF was 49±9ms at RA. and 45±l7ms at LA (Table I). Preventive
pacing at RA was not effective against premature stimuli at RA (WI-AF:55±I Ims,
p=0.17). On the other hand it significantly shortened WI-AF by premature stimuli at LA
(23±9ms. p<0.()l). This was due to a marked lowering of ULI-AF from I52±9ms to
122±l4ms (p<0.0l). In neither case preventive pacing affected the lower limit of
inducibility (AERP) and the same degree of prematurity was achieved during all modal-
ities of preventive pacing. Preventive pacing at LA showed the opposite effect. Now. ini-
tiation of AF by premature stimuli originating in the RA was reduced (WI-AF:23±I Ims,
p<0.01). whereas it had no effect on induction of AF by premature stimuli at LA (Wl-
AF:52±IOms, p=0.35). Again the shortening of WI-AF was due to a lowering of ULI-AF
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(from l50±6ms to 125±9ms, p<0.01). Preventive bi-atrial pacing failed to shorten WI-
AF both in case of premature stimuli delivered at RA (56±12ms, p=0.69) and LA
(54±8ms. p=(). 13). Pacing at BB exerted the largest preventive effect and shortened the
window of inducibility to 25±1 lms (RA) and I7±8ms (LA, p<0.01). Again this protec-
tive effect was due to lowering of LLI-AF to 123±15ms and 119±8ms (p<0.01).
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MECHANISMS OF PREVENTIVE PACING
In all cases, the preventive effect of pacing was due to prevention of critical conduction
of premature beats at BB. This is clearly illustrated in Fig.5. In cases in which pacing
failed to prevent AF. the pa-mature stimulus was blocked at BB„,j (fragmented, low-volt-
age potentials associated with early proximal re-excitation). When pacing prevented
induction of AF. the premature impulse conducted normally along BB„,j(high-amplitude
negative deflections). The prevention of conduction block of premature beats could be
explained by marked prolongation of the pa-mature interval at BB„,^ . When AF was pre-
vented AI-A2 at BB,,,,,, was longer than l^lms compared to <156ms when pacing failed
to prevent AF.
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In Fig.7 the mechanisms of preventive atriai pacing are illustrated schematically.
Prolongation of the premature interval at the area of block by preventive pacing is due
to pre-excitation of the area of block relative to the site of ectopy (left panel). As illus-
trated in the right panel, the prematurity at the area of block (A1-A2,,,,,J is determined
by the sum of the prematurity at the site of ectopy + the conduction time from the sile of
preventive pacing to the site of ectopy @ - the conduction lime from the site of pacing
to the area of block © + the conduction time of the premature beat to the area of block
3). In Table 2. these conduction times and the resulting prolongation of the premature
interval at the area of block are given for all goats. Preventive pacing at RA only pro-
longed the premature interval of /^/? ectopic beats (by 48±14ms), whereas preventive
pacing at LA only prolonged the prematurity at BB during n#/j/ eclopy (by 39±6ms).
Preventive bi-atrial pacing did not prolong the premature intervals of either right or left
ectopic beats. Preventive pacing at BB. prolonged the premature interval of both right
and left premature stimuli (by 38±8ms and 5()±l5ms. respectively) because in this case
the area of block was always pre-excited relative to the site of ectopy.
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Discussion
SHORTENING OF THE WINDOW OF INDUCIBILITY BY PREVENTIVE
ATRIAL PACING
The main findings of the present study in the caprine model of AF show that: (I)
Bachmunn's bundle is an area of critical conduction of premature beats. The fragment-
ed low-voltage potentials recorded at BB can be the result of non-uniform anisotropy,
slow discontinuous conduction, longitudinal dissociation or conduction block. The com-
bination of low-voltage potentials together with early re-excitation proximal to this area
strongly suggest that initiation of AF was due to conduction block and reentry at BB.
Critical conduction of premature impulses along BB can be explained by a considerable
longer refractory period at the mid-portion of BB. (2) Atrial pacing can prevent but not
completely abolish the initiation of AF by single premature beats. The shortening of the
window of itulticibility was due to prevention of AF by /<//«' premature beats. Atrial pac-
ing could not prevent the induction of AF by very early premature beats. (3) In neither
case pacing affected the atrial effective refractory period and the same degree of prema-
turity was achieved during all modalities of preventive pacing. (4) The mechanism of
prevention of AF is a prolongation of the premature interval at the area of critical con-
duction (Hachmann's bundle). During atrial pacing, the premature interval at the area of
block cun be calculated by the following formula: Al-A2g^k = Al-A2,^,,^ + (CTp„, „^„„
- CTiv.-i..Hk»i) + ^Ti...T»i..Bi.»k- (5) The optimal site for preventive pacing is close to the
critical area of block and remote from the origin of premature beats. In this case the area
ol block is maximally pre-cxcilcd relative to the site of ectopy. Other pacing sites remote
from the area of block may be as effective as long as the area of block is equally pre-
excited. Hi-airial pacing can be less effective than single-site pacing when one of the
pacing sites is close to the origin of premature beats.
IS THERE AN OPTIMAL PACING SITE TO PREVENT ATRIAL
FIBRILLATION?
The present findings suggest that Bachmanns bundle (area of critical conduction) may
be an effective pacing site for preventive atrial pacing. This finding is in agreement with
a recent clinical study by Bailin et al. showing that in patients with paroxysmal AF pac-
ing at Bachmanns bundle had an incremental benefit (compared to right atrial pacing)
in the prevention of chronic AF." However, it should be emphasized that our caprine
model of AF docs not emulate the more complex substrate of different types of human
AF. Several differences have to be taken into consideration comparing our experimental
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findings to preventive pacing in human AF. First of all. the .vn/i.tmirr for initiation of AF
might be very different in patients compared to normal, electrically remodeled caprine
atria. Although also in patients the atrial septum, including the ostium of the coronary
sinus and Bachmann's bundle, seems to be a preferential site for intru-alrial conduction
delays. '*" abundant patho-anatomical changes may occur in the atrial myixardium as a
result of ageing, atrial dilatation and coronary artery disease.'"'" in such diseased atria.
iHher areas may act as critical sites of conduction block and reentry. In addition, the /n,»»-
j j m of human AF may be different from the single premature stimuli applied in our
experimental study. Although also in humans single premature beats have been shown to
initiate AF. ' other onset-mechanisms like multiple premature beats, focal alrial tachy-
cardia and atrial flutter may trigger AF as well. In these cases, the efficacy and mecha-
nism of preventive pacing may be different from the mechanisms shown in our experi-
mental study. Finally, the beneficial effect of the observed shortening of the window of
inducibility by atrial pacing may be rather limited. Since in patients with AI the window
of inducibility may be wide," a reduction by 30 to 40ms as found in our study may exert
only a negligible effect. In such case choosing an optimal site for preventive pacing
might have only a minor effect on recurrences of AF.
Nevertheless, although our observations can not provide guidelines for preventive pac-
ing in humans they may help to gain insights into the basic mechanism(s) of prevention
of AF. Our findings imply that the optimal site for preventive pacing depends on the site
of origin of atrial premature beats and the location of areas of critical conduction. The
best pacing site may differ from case to case and therefore should be determined on an
individual basis. Characterization of the nature of triggers of AF and localization of areas
of critical conduction delay, may help to define the optimal site for preventive pacing.
SINGLE-SITE VERSUS MULTI-SITE PACING
Single-site pacing at the right atrium was found to reduce recurrences of AF in patients
with sinus node dysfunction.'' ' ' According to our data, this might not only be due to
prevention of bradycardia-dependent triggers but also by lowering the chance of initia-
tion of AF by atrial premature beats. In our study, pacing at the right atrium was effec-
tive in preventing AF induced by te/f atrial premature beats. Since in the majority of
patients with paroxysmal AF the atrial ectopic beats originate from the pulmonary veins,
the efficacy of right atrial preventive pacing in these cases might be explained by the
mechanisms as proposed in our experimental study. Clinical studies on the additional
benefit of bi-atrial pacing are controversial.''' ' Daubert et al. showed a marked effect
of bi-atrial pacing on recurrent atrial arrhythmias in patients with advanced inler-atrial
conduction delay.' After coronary artery surgery, bi-atrial pacing was found to be more
as well as less effective than right atrial pacing."' Like in our experimental study, in one
clinical study, bi-atrial pacing was found to be less effective than single-site pacing in
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preventing AF by premature stimuli.-' Saksena et al. reported a beneficial effect of dual-
site pacing in the right atrium. Pacing both at the ostium of the coronary sinus and the
high right lateral atrium, prolonged the arrhythmia-free interval more than pacing at the
right atrium or coronary sinus alone (195±96 days vs I43±l 10 days).' These clinical
studies are not necessarily conflicting with our experimental findings. In case of an opti-
mal single pacing site multi-site pacing could be of limited value, whereas in case of a
more complex atrial substrate with multiple areas of conduction delay, multisite pacing
might be better than single site pacing. On the other hand, multi-site (or dual-site) pac-
ing may also have favorable hemodynamic effects explaining their incremental benefit
in the prevention of AF. *
Limitations
The limited epicardial mapping, does not allow complete reconstruction of all the com-
plex interactions between ectopic premature beats and the different pacing modes to pre-
vent initiation of AF. Because ol the absence of endocardial recordings the 3-D structure
of the atria was not taken into account.
Another limitation our study is that we did not study the effects of preventive atrial pac-
ing on initiation of AF' by .v/>o/mm<7>//.v atrial premature beats (which are virtually absent
in the goat) and //i/</n/>/e atrial premature beats.
Table I. Window of Inducibilily of AF by Single Premature Beals (Baseline Values).
Goats
l
2
3
4
5
6
Mean
SD
LOWER LIMIT OF
(MS)
Sl-S2atRA
I(X)
104
92
96
106
105
101ms
±6
INDUCIBILITY
Sl-S2atLA
108
122
96
111
112
97
108ms
±10
UPPER LIMIT OI' INDUCIBILITY
(MS)
Sl-S2atRA
145
150
144
150
160
150
150ms
±6
Sl-S2atLA
150
145
164
140
160
155
152ms
±9
WINDOW OF INDUCIBILITY
(MS)
SI-S2atRA
45
46
52
54
54
45
49ms
±9
Sl-S2atLA
42
23
68
29
48
58
45 ms
±17
Table 2. Prolongation of the Premature
Interval at the Area of Block (Bachmanns bundle) during Preventive Pacing (6 goats).
Old,PaccioBtat
Prolongation of
the Premature
Interval at BB„,
PREVENTIVE PACING
ATRA
Premature Premature
Stim. at RA Stim. at LA
25±4 66±10
2±1 83±7
24±4 31±12
1ms 48ms
±14
PREVENTIVE PACING
AT LA
Premature Premature
Stim. at RA Stim. at LA
57±9 33*13
75+4
21±1
6±3
29±13
39ms
±6
2ms
±3
PREVENTIVE BI-ATRIAL
PACING
—
Premature Premature
Stim. at RA Stim. at LA
25±4 33±13
2±1 5±4
25±4 3O±14
3ms
±2
2ms
±3
PREVENTIVE PACING
ATBB
Premature Premature
Stim. at RA Stim. at LA
17±3 20±6
36±10 41±10
21±1 3O±12
40ms
±9
50ms
±16
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Chapter 6
Pro-fib rillatory Effects of Verapamil but not of
Digoxin in the Goat Model of Atrial Fibrillation.
Mattias F. Duytschaever. MD; Clifford J. Garratt, MD;
Maurits A Allcssie, MD. PhD
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Abstract
Background: Vcrapamil (V) and digoxin (D) have been shown to modulate tachycardia-
induced atrial electrical remodeling. The goal of the present study was to determine the
direct effects of V and D on AF, before and after electrical remodeling.
Methods and Results: In 6 goats we measured the cycle length (AFCL) and duration of
AF (DurAF) of 50 consecutive induced paroxysms, before (t=0) and after 24h (t=24) of
electrical remodeling. During AF conduction velocity (CV\,). refractory period (RP -^J
and the type of AF ( I l l - I l l ) were determined. V was administered by a loading dose of
0.1 mg/kg. followed by a continuous (2-hour) infusion of 5 (ig/kg/min. D was given
intravenously as a single bolus of 0.02 mg/kg. At t=0 and 1=24. D and V caused a sig-
nificant slowing of the ventricular rate of >40*/f. D had no effect on DurAF. AFCL, C V „
or R l \ | . Infusion of V had a direct pro-arrhythmic effect. Both at t=0 and t=24. AFCL
and RPAI were shortened by about 15%. During acute AF, V prolonged the average dura-
tion of AF-paroxysms from 7 to 16 seconds. After 24 hours of AF. the proarrhythniic
effect was much stronger. Shortly after start of the infusion (6±2min) V converted parox-
ysmal into sustained AF. As long as V infusion was maintained, in all goats AF no longer
terminated. This effect was associated with an increase in AF-fragmenlation from type 1
to type II-II1.
Conclusions: Vcrapamil shortens AFCL and RP„ in the presence and absence of elec-
trical remodeling. After 24 hours it exerted a marked proarrhythniic effect and convert-
ed paroxysmal (type-I) into sustained (type-Ill) AF. In contrast, digoxin had no effect on
rate or stability of AF.
Key Words: Atrial fibrillation- Electrical Remodeling- Verapamil- Digoxin- Pro-
anhyllunia.
EFFECTS OF VMAPAMU
List of Abbreviations
AF : Alrial Fibrillation
V : Vcrapamil
D : Digoxin
AFCL : Atrial Fibrillation Cycle Length
RR^ : Ventricular Rate during AF
DurAF : Duration of induced AF episodes
TypeAF : Complexity of AF (type l-ll-lll)
CV„„ : Atrial Conduction Velocity during Slow Pacing (SI -S1:4(X)ms)
CV„ : Atrial Conduction Velocity during AF
AERP«, : Atrial Effective Refractory Per iod dur ing S low Pac ing (SI -SI : 4 (X)ms)
RP*, : Atrial Refractory Period during AF
Introduction
Digoxin and verapamil are commonly used to control (he ventricular rate during alrial
fibrillation (AF).' Recent experimental and clinical studies suggest that digoxin and ver-
apamil might influence the natural course of AF.'' Tieleman et al. demonstrated that ver-
apamil attenuated the tachycardia-induced shortening of atrial refractoriness (electrical
remodeling).- In contrast, digoxin had no detectable effect on remodeling, but slightly
delayed its recovery (reverse electrical remodeling).' Clinically, there are indications that
patients treated with calcium lowering drugs have fewer relapses of AF after electrical
cardioversion. whereas digoxin may increase the likelihood of recurrences.'
However, little is known about the direct effects of digoxin and verapamil on the elec-
trophysiological properties of the atria and on the characteristics of atrial fibrillation. The
goal of the present study was to compare the effects of both drugs on the refractory peri-
od and conduction velocity during AF and to determine the pro-and antiarrhythmic
effects on rate and duration of AF. To investigate whether AF-induced electrical remod-
eling affected the action of digoxin and verapamil. they were administered both during
acute AF (no remodeling) and after 24 hours of AF (remodeling).
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Methods
THE GOAT MODEL OF ATRIAL FIBRILLATION
Six goats weighing between 42 and 74kg (56112) were used for this study. Animal han-
dling was carried out according to the Dutch Law and the European Directive for pro-
tection of vertebral animals. Anesthesia was induced by intravenous administration of
Nesdonal (I5mg/kg) and maintained by ventilation with halothanc (1-2%) and a mixture
of (); and N,O. The chest was opened through a left intercostal thoracotomy. Three teflon
felt plaques, each containing 23-30 silver electrodes, were sutured to the atrial epicardi-
um (FigI). Two oval-shaped plaques (3.5x2.5cm, 30 electrodes, inter-electrode distance
4mm) were sutured on the free wall of the right (RA) and left atrium (LA). One strip of
6xlcm. containing 23 electrodes (inter-electrode distance 6-1Omm), was pulled through
the sinus between the atria and the aortic root and sutured to the atrial appendages. A
plaque containing 4 electrodes was sutured on the free wall of the left ventricle (LV). A
silver plate was left under the skin of the thorax to serve as indifferent electrode. The
electrode leads were tunneled subcutaneously to the neck and exteriorized by three 30-
pin connectors (Lemosa®). Post-operatively the animals received buprenorfine
(Temgesic®) for 2-4 days. Hxperiments were started 3-4 weeks after surgery.
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EXPERIMENTAL PROTOCOL
The effects of verapamil and digoxin were measured both before anil alter electrical
remodeling by 24 hours of AF. AF was maintained by a fibrillation pacemaker. This
custom-made computer program automatically delivered a I-second burst of stimuli
(50H/. 4xdiastolic threshold) to a pair of atrial electrodes as soon as sinus rhythm was
delected (FigI). By these automatic bursts of stimuli. AF could be maintained continu-
ously during 24 hours as has been previously described."
First the effects of verapamil were studied both during normal sinus rhythm (no remod-
eling) and after 24 hours of AF. Then digoxin was administered both before and after AF-
induced electrical remodeling. Between all 4 experiments the goats were left in sinus
rhythm for at least one week. During this period the atria recovered completely from
earlier remodeling and drug administration.' Before each drug a baseline study was
performed. First, during regular pacing (S,S,:4(X)ms) the left atrial effective refractory
period (AF.RP,,,) and conduction velocity along Bachmann's bundle (C'V^,,,) were meas-
ured. The double row of electrodes on Bachmann's bundle was used to verify propaga-
tion parallel to the electrodes. Cycle length and duration of AF were measured during 50
consecutively induced episodes of AF. The mean AFC!, and RR-interval were deter-
mined from 1(X) consecutive AF and RR cycles from unipolar left atrial and ventricular
electrograms. Verapamil was administered by a loading dose of 0.1 mg/kg. followed by
a continuous (2-hour) infusion of 5 ng/kg/min. Digoxin was given intravenously as a
single bolus of 0.02 mg/kg. These dosages were chosen, based on previous studies in
the goat ' ' and because they prolonged the average RR-interval during AF to a similar
extent (±45%). Immediately after drug administration, repeated induction of AF was
continued for a period of 2 hours. The mean AFCL and RR interval were measured every
15 minutes after start of the infusion, whereas the duration of the paroxysms of AF was
monitored continuously for a period of 2 hours. After 1 and 2 hours of drug administra-
tion, the atrial refractory period and conduction velocity were measured during regular
pacing with an interval of 400 ms.
ELECTROPHYSIOLOGY OF AF
The type of atrial fibrillation (type,,.), the conduction velocity and the refractory period
during AF were measured after I and 2 hours of drug infusion. To determine the type of
AF (I-1I-III) fibrillation maps were recorded from the free wall of the left and right atri-
um. Time windows of 4 seconds were analyzed excluding the first and last seconds of
AF. The software used for mapping (custom-made) included an algorithm for automatic-
detection of the intrinsic negative deflections of unipolar electrograms and interactive
editing of local activation times. Isochrones were drawn manually at 5-ms intervals.
Type I AF was defined by broad single wavefronts propagating without apparent
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conduction delay. Type II AF was characterized either by the presence of two wavelets
or by lines of intra-utrial conduction block. During type III. multiple wavelets were pres-
ent under the mapping array which continuously changed their size and position. During
a 4 second-sample of AF (25 to 40 AF cycles) beat to beat variations in AF pattern were
observed. The degree of disorganization during AF was determined by calculating the
percentage of beats with a type II or III pattern.
To measure the atrial conduction velocity during AF. the fibrillation maps were triangu-
lated and the local conduction vectors calculated from the activation times at the corners
(Fig 2). When neighboring electrodes were activated almost simultaneously (either by
collision or by epicardial breakthrough of fibrillation waves) high virtual conduction
velocities were measured. Values of more than 140 cm/sec were discarded from analy-
sis. The CV i^ histogram, obtained in this way, contained about 700-900 data points. The
median value was taken as an index of conduction velocity during AF.
Activation map Vector map Velocity Histogram
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The refractory period during AF was measured during regional entrainment of the free
wall of the left atrium with a pacing interval equal to the median AFCL (Fig 3). A pair of
electrodes in the center of the mapping array was selected for stimulation whereas local
capture was verified at a neighboring electrode 4 mm from the pacing site. Capture was
defined by the absence of R-waves and a short and constant latency between stimuli and
response. Alter 8 entrained beats, single premature stimuli were applied starting well
within the refractory period. In the upper panel of Fig 3. a premature stimulus w ith a cou-
pling interval of 112ms did not capture the atrium. The post-stimulus electrogram
appeared after a long latency and exhibited a clear R-wave. Failure of capture was con-
tinned b\ the activation map. showing a fibrillation wave propagating from left to right
under the pacing electrode. A coupling interval of 116ms (lower panel. Fig 3) resulted in
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local capture. The activation map showed radial spread from the pacing site at the center
ot the mapping array and the neighboring clcctrogram exhibited a similar response as dur-
ing the previous entrainment of AK The shortest coupling interval that captured the atri-
um during AF wa.\ not constant. When stimuli with the same coupling interval were
applied repeatedly, capture sometimes occurred and sometimes not. This shows that,
instead of deterministic, the RP„ is a probabilistic measurement. Therefore each coupling
interval was repeated 10 times before it was incremented by 2 ms. Because we were inter-
ested in the largest possible excitable gap during AK the refractory period during AI- was
taken as the shortest coupling interval that resulted in 20 '* of capture (2 of 10 attempts).
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135 135 J 135 135 I 135, 135 I 116
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STATISTICAL ANALYSIS
Data are presented as mean±SD. In case the data were not normally distributed the medi-
an value and its range are given. Statistical analysis was performed by the paired
Student's t test or the Wilcoxon matched pairs signed ranks test. A p-value of less than
0.05 was considered as statistically significant.
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Results
EFFECTS OF DIGOXIN AND VERAPAMIL ON ATRIAL RATE AND
STABILITY DURING AF
A representative example of the effects of digoxin and verapamil on RR interval and
AFCL is given in Fig 4. During acute AF (no remodeling) the average RR interval was
573±l()4ms and the mean AFCL I64±l Ims. Digoxin progressively slowed the ventric-
ular rate during the first 15 minutes after administration of the single bolus. Then, dur-
ing 2 hours, the average RR interval remained constant (9()8±3I5 ms). AFCL remained
unchanged (I64±13ms). Verapamil equally prolonged the RR interval to 849±365ms.
However, in contrast to digoxin. the AFCL was shortened to 138±l2ms. After 24 hours
of AF. the KK interval was unchanged (630±84ms), while the AFCL had shortened lo
132±l2ms (atrial electrical remodeling). Again digoxin prolonged the RR interval
(927±3l9ms). but left the AFCL unchanged (I3()±9ms). Infusion of verapamil pro-
longed the KK interval lo 908±.Wms and again shortened AFCL. As a result of the com-
bination of electrical remodeling and verapamil, the AFCL became as short as l()9±15ms
(lower right panel).
Control
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The effect on the duration of AF is illustrated in Fig 5. In the non-renuxleled state (acute
AF) the AF paroxysms were short lasting (median 6 seconds, range 2-24). Digoxin had
no effect on the duration of the AF episodes, whereas verapamil (lower panel) slightly
prolonged the AF paroxysms (median 15 seconds, range 2-72 sec). Alter 24 hours of
electrical remodeling, the AF paroxysms lasted longer with a median duration of 54 sec-
onds (range 8-230 sec). Again digoxin did not alter the duration of AF. Verapamil now
had a dramatic effect on the stability of AF. During the first 5 minutes after start of the
infusion. AF was still self-terminating (7 episodes). However, the 8" paroxysm of AF.
induced after 5 minutes, no longer terminated and persisted as long as verapamil was
given (2 hours).
A F
Control
6 .»•«•
Digoxin
Verapamil
/5 .vec
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Analysis of fibrillation maps showed no effect of digoxin on the degree of fragmenta-
tion, either during acute AF or after 24 hours of electrical remodeling. However, admin-
istration of verapamil increased the fragmentation of the fibrillation waves in the remod-
eled atria (24h AF). In Fig 6 an example is given. Before verapamil was given (upper
panel), the AFCL was I I9±l Ims. The majority of the electrograms consisted of single
high-amplitude complexes, separated by isoelectrical segments. The fibrillation maps
revealed single broad wavefronts propagating without much conduction delay (type I).
Only incidentally dissociation by a line of functional conduction block was observed
(type II). Administration of verapamil accelerated AF (AFCL 99ms) and the fibrillation
electrograms became more fragmented and lower in amplitude. The fibrillation maps
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now showed a more complex activation pattern. Often multiple wavelets were seen sep-
arated by lines of functional conduction block (type II and III).
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In Fig 7 and Table I the effects of digoxin and vcrapamil on the characteristics of AFare
given for all six goats. Both during acute AF and after 24 hours, digoxin and vcrapamil
caused a similar prolongation of the RR interval by > 40 9h In all goats, administration
of digoxin progressively slowed the ventricular rate during the first 15 minutes, after
which the average RR interval remained constant for 2 hours. Digoxin had no effect on
AFCL. neither during acute AF (151±I7 versus I51±l5ms) nor after 24 hours of AF
(I I5±I2 versus 116±l3ms). In contrast, vcrapamil clearly accelerated the rate of AF. In
non-remodeled atria. AFCL shortened from 152±I5 to 129±9ms (-15%) and in remod-
eled atria from I21±l() to l()2±8nis (-16'»). The duration of AF was not influenced by
digoxin. neither beton." nor after remodeling. Vcrapamil prolonged the duration of AF.
The median duration of paroxysms of a««/«* AF was prolonged from 7 to 16 seconds
(p=O.(K>). After AF of 24h duration, the effect of verapamil on the stability of AF was
more pronounced. Only during the first 6±2 minutes of verapamil infusion. AF was still
self-terminating. Then, verupumil converted paroxysmal into sustained atrial fibrillation
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in all 6 goats and as long as verapamil infusion was mainlained (2 hours), AF no longer
terminated.
Whereas the degree of fragmentation of AF was not affected by digoxin. the effects of
\erapamil »ere largely determined by the degree of electrical remodeling. During acute
AF verapamil had no effect on the complexity of AF. However, after 24 hours of AF-
induced electrical remodeling, verapamil shifted AF from type I to type 11-111. The
percentage of type II+III beats after administration of \crapamil was 96±6 '* compared
to 25±11** at baseline (rxO.OI).
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EFFEaS OF DIGOXIN AND VERAPAMIL ON ATRIAL REFRACTORY
PERIOD AND CONDUCTION VELOCITY
Both digoxin and verapamil had no effect on atrial conduction during slow pacing cither
before or after AF-induced electrical remodeling. Conduction during AF was also not
changed by digoxin (acute AF: 75±I5 versus 76±l2cm/s; 24h of AF:74±8 versus
74±10cm/s) (Table I). The effects of verapamil on conduction during AF are illustrated
in the CV„ histograms given Fig 8. During acute AF. verapamil had no effect on the
CV^ histogram. However, after 24 hours of AF, the histogram was clearly skewed to the
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left, indicating an increase in the incidence of intra-atrial conduction block. The contri-
bution of local conduction velocities of <20cm/s increased from 0 to 12% and the
percentage of CV ,^. between 20 and 40 cm/s increased from 4 to 18%. As a result the
median CV\, decreased from 80 to 6()cm/s. In Table 1 the effects of digoxin and vera-
pamil on CV\, both during acute AF and 24h of AF are given for all six goats.
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" " IM) " " w o
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II») 100
»I «0
20 20
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20 411 MI HO lim 120 140 20 4(> MI HO 101) 120 140
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"» .«- • '"'IMI
100
M)
20
4(1 Ml HO IKI I M 1*) M 4(1 Ml Ml HI) 120 140
TV, , (cm/s) C V M I'•"'"/*»
. f Vnii/iirfiiw» ir/<« ifv Aftr»vni»i.t i/uriny .4>' taif/i /*/««• <W ii/frr irm/wmi7. /n
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The atria) refractory period, both during slow pacing and atrial fibrillation was not affect-
ed by digoxin (Table I). During slow pacing in non-remodeled atria also verapamil had
no significant effect on atrial refractoriness (157119 versus 152119ms). Because in
remodeled atria verapamil resulted in persistent AF. the AERP*,, could not no longer he
determined. The shortening of the AFCL by verapamil was paralleled by a shortening of
the atrial refractory period during AF. In Fig 9. an example of the shortening of RP^ by
verapamil is shown During control, the shortest coupling interval that captured the atri-
um during cmrainmcnl of AF was 116ms (upper panel). Verapamil accelerated AF to a
median AFCL of 108115ms. During regional entrapment of AF with a pacing interval
of 108ms. the shortest coupling interval which captured the atria was now 94 ms (lower
panel). In Table I the average results were listed. During acute AF. RP^ shortened from
130114 to 113111ms (-13%. p<0.0l). After 24 hours of AF. verapamil shortened the
RP^ from 10617 to 90K» ms (-16%. p<0.0l).
P*O-FIMIllATCMtV ErffCTS Of \*RAPAMIl IO9
Control
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Discussion
Both experimental and clinical studies have suggested that digoxin and verapamil might
alter the natural course of atrial fibrillation by modulating tachycardia-induced electrical
remodeling. •' " AF-induced electrical remodeling was first described by Wijffels et al.
as a progressive shortening of the atrial refractory period during the first days of AI'.'
Two years later Yue et al. showed that the shortening of the action potential was due to
downregulation of the L-type calcium current." It is believed that this process of electri-
cal remodeling is mediated by intracellular calcium overload resulting from the extreme-
ly high atrial rate.
Initially, experimental and clinical studies demonstrated that verapamil could attenuate
tachycardia-induced electrical remodeling." " Patients treated with intracellular calcium
lowering drugs experience fewer relapses of AF after electrical cardiovcrsion/ However,
more recently it has been shown that long-term tachycardia-induced shortening of atrial
refractoriness can not be prevented by verapamil.'
Digoxin. which increases intracellular calcium content, had no significant effect on the
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time course of electrical remodeling, but delayed its recovery (reverse electrical remod-
eling).' Clinically, there are indications that digoxin might increase the likelihood of
recurrence of AF.'
DIGOXIN
Clinical studies on the effects of digoxin on the stability of AF are controversial. Some
authors suggested that digoxin might cardiovert recent onset AF. " whereas others report-
ed that digoxin prolonged the duration of paroxysmal AF." In isolated human atrial tissue
it has been shown that ouabaine shortens the atrial action potential due to its parasympa-
Ihctic effect." Rawles et al. hypothesized thai this might increase the atrial rate of AF."
In the present study, we showed that (1) intravenous administration of digoxin (0.02
mg/kg) had no effect on atrial llbrillation cycle length, degree of dissociation of AF waves
or atrial electrophysiology during AF. neither in the non-remodeled and remodeled atria:
(2) digoxin had no effect on the duration of electrically induced AF episodes. Even in the
during digoxin administration. These data are in agreement with recent randomized stud-
ies demonstrating that digitalization of patients with recent onset AFdoes not increase the
likelihood of restoration of sinus rhythm."' Obviously, intravenous administration of
digoxin does not exert much parasympathetic effect on the atrial myocardium. The lack
of effects of digoxin on AF could not be due to inadequate plasma levels or insufficient
time to reach its maximal effect because, in all goats, after 15 minutes of digoxin admin-
istration a maximal prolongation of the RR-intcrval 040%) was observed. The early
onset of prolongation of the RR-interval is in agreement with the clinical study by Powell
et al. in which a maximal efleet on atrio-ventricular conduction was already reached 10-
20 minutes alter intravenous administration of digoxin (lmg).'"
PRO-FIBRILLATORY EFFECT OF VERAPAMIL
Both experimental '" and clinical •"" studies have shown that vcrapamil enhances the main-
tenance of electrically induced AF episodes. However, in non-remodeled atria this pro-fib-
rillatory effect was only moderate. In patients vcrapamil prolonged the duration of electri-
cally induced AF from 5 to 39 min. but all paroxysms were still self-terminating.'
Friedman et al. suggested thai the \erapamil-induced increase in eatecholamines '" ' pro-
moled the maintenance of AF but they could not identify the electrophysiological mecha-
nism by which this occurred. In vitro, calcium antagonists cause a decrease in the action
potential duration due to shortening of the calcium dependent plateau of the action poten-
tial." However, clinical studies showed no effects of verapamil on the atrial refractory pen-
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od during slow pucing (S,S,: 500-700ms).' ' Only limited data are available on the effects
of verapamii at high atria! rates."
In the present study we showed that ( I ) the direct pm-arrhylhmic effect of verapamii was
based upon an increase in the atrial rate during AF due to a shortening of the refractory
period at AF rates, both in the presence and absence of electrical remodeling but that (2)
the pro-fibrillalory efl'ect of verapamii on stability of AF was markedly enhanced by elec-
trical remodeling. In non-remodeled atria, the pro-fihnllaiory effect of \crupamil was
negligible and resulted in a non-significant prolongation of the average duration of AF
from 7 to 16 seconds. In contrast, in electrically remodeled atria, verapamii converted
paroxysmal into sustained atrial fibrillation, shortly after start of the infusion. As long as
verapamii infusion was maintained (2 hours). AF no longer terminated.
Also in the present study there was no effect of verapamii on atrial refractoriness during
sltm pacing. The preferential shortening of the refractory period during high atrial rales
might be due to a rate-dependent block of the L-type calcium channels. Due to then low
lipid solubility, phenylalkylamines (verapamii) access their intraccllulur binding site pre-
dominantly via the open channel and because these compounds are charged they unbind
slowly from their receptor.* Therefore verapamii exhibits a marked use-dependent Mock.
Since during AF the excitable gap comprises not more than 20-25'i of the cycle length,
the L-type calcium channels are in the open state more than 75% of the lime. This might
explain the preferential shortening of the atrial refractory period by verapamii during AF.
An alternative explanation is that shortening of the atrial refractory period at high rales is
mediated by the neurohumoral effects of verapamii. In a canine model of AF', sympathetic
stimulation shortened the atrial refractory period especially a( high atrial rates, resulting in
a shortening of the AFCL by 12 $-.-" This resulted in a slight prolongation of AF' duration
similar to the pro-fibrillalory effect of verapamii in the non-remodeled atria of the goat.
In the present study we demonstrated that the efl'ect of verapamii on AF stability strongly
depended on the degree of electrical remodeling. It is very likely that the profihrillatory
effects of electrical remodeling and of verapamii both are based upon a shortening of the
atrial refractory period. This will shorten the pathlenglh and increase the number ol alrial
fibrillation waves. The resulting increase in the average number of intra-alrial circuits
could explain the increased stability of AF.'" However, since the atrial refractory period
(and circuit size) have to be shortened below a critical value. * only after the additive effect
ot electrical remodeling and verapamii. fibrillation became sustained. This is supported by
the observation that only in the remodeled atria, verapamii resulted in a marked increase
in the fragmentation of the atrial activation during AF.
It is unclear whether verapamii would also shorten the RP^, in chronic AF. since Yue et al.
" reported a significant reduction in the L-type calcium current after 6 weeks of rapid
atrial pacing. In addition, after long-standing AF. structural changes may occur which
could alter the effects of verapamii on atrial electrophysiology. A recent study by Ramanna
et al. reported that also in patients with chronic AF verapamii increases the atrial rate dur-
ing AF.^ This implies that also after long-term electrical remodeling (>24h AF), verapamii
could shorten the refractory period during AF.
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CLINICAL IMPLICATIONS
The choice of drugs for rate control of AF might not only be determined by the efficacy
of regulating the ventricular rate but also by their possible effects on atrial fibrillation
itself. This is emphasized by our present study in which digoxin and verapamil exerted
a similar effect on the RR interval but different effects on rate and stability of AF. In
patients with paroxysmal AF, the proarrhythmic effect of verapamil might prolong the
duration of AF paroxysms. When an episode of AF has proceeded long enough for elec-
trical remodeling to occur, rate control by verapamil might even reduce the likelihood of
spontaneous termination of AF. Furthermore, the acceleration of atrial rate might also
reduce the efficacy of chemical cardioversion.
LIMITATIONS OF THE STUDY
The question whether the observed pro-fibrillatory effect of verapamil is mediated
through an increase in sympathetic tone remains unanswered. The occurrence of severe
brudycardia in the goat by the combination of verapamil and beta-blockade precluded
experimental evaluation of this hypothesis. Furthermore, the direct effect of verapamil as
described in this paper is clinically relevant, since also in patients verapamil is prefer-
ably administered in the absence of beta-blockade.
The different experiments were not performed in a random order. However, sufficient
time was allowed between experiments for complete washout of the previously admin-
istered drug or complete recovery from electrical remodeling (reversed remodeling)." In
addition, serum levels of digoxin and verapamil were not measured. However, the sig-
nificant slowing of the ventricular rate during AF (>4()<#) by verapamil and digoxin
implied adequate serum levels of both drugs.
Since, even alter prolonged periods of AF. the goat does not get spontaneous paroxysms
of AF. it is unknown whether digoxin or verapamil would affect the triggers for initia-
tion of AF. Also it remains to be seen how these drugs affect AF of longer than 24h
duration. However, preliminary reports suggest that also in patients with chronic AF, ver-
apamil increases the atrial rate during AF.**
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Table l. lif'f'ects of digoxin and verapamil on acute and 24-hours AF.
Acute AF
Control
Digoxin
A%
Control
Verapamil
A *
24h of AF
Control
Digoxin
A%
Control
Verapamil
A**
RRM
(ms)
424±72
624±77
+47<7r
(p<0.01)
469±U2
671±IO9
+437r
(p<O.OI)
447*143
630*153
+41%
(p<0.02)
460±I20
666±120
+45%
(p<0.01)
AFCL
(ms)
151+15
151±17
n.s.
152±15
129+9
-15%
(p<0.01)
II6±I3
I15±12
n.s.
I21±1O
102±8
-16%
(p<0.01)
DurAF
(s)
10 (4-34)
11 (4-175)
n.s.
7 (4-86)
16 (4-132)
(p=0.06)
76 (30-284)
72 (34-587)
n.s.
74(24-140)
Sustained
-
Type II+III
(%)
29±12
32±1O
n.s.
29±8
26±19
n.s.
30±19
28±13
n.s.
25±11
%±6
+291%
(p<0.01)
CV«,
(cm/s)
136±17
133±14
n.s.
I34±12
138±I5
n.s.
I38±I5
I34±I6
n.s.
136±8
-
-
cv„
(cm/s)
75±I5
76±I2
n.s.
77±I4
8O±I2
n.s.
74*8
74±10
n.s.
77±I5
42±I9
46%
(pcO.05)
AERP«,
(ms)
151*31
I47±32
n.s.
I57±I9
152*19
n.s.
116*23
114*25
n.s.
120*12
-
-
RP*K
(ms)
129*24
129*27
n.s.
130*14
113*11
-13%
(p<0.0l)
100*9
100*10
n.s.
IO6±7
90*6
-16%
(p<0.01)
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Abstract
Background: Recently, the temporal excitable gap during atrial fibrillation (AF) has
been identified as a vulnerable parameter for cardioversion of AF. In this study, we
evaluated 5 methods to measure the refractory (RP^) and excitable period (EP^) during
persistent AF.
Methods and Results: In 11 goats, instrumented with 83 cpicardial atrial electrodes,
persistent AI- (43±34days) was induced with a median-AFCL of 98±l4ms. To measure
RP,u, premature stimuli were applied to the center of the electrode array on the right or
left atrium. The RP*, measured by /M<//>/>/n# of premature stimuli was 70±12ms (gold
standard). The RP.„ determined during c/irr<//nmc/ir of AF was 77±17ms (R':0.88,
p<O.()l). Statistical analysis of the effects of wm/mw/c«/ .vf/'wi///; (each coupling
interval: l(K)x) on the AFCL histogram yielded an RP„ of 7()±13ms (R':0.94. p<0.01). A
further simplification was to apply slow //.<r«/-ra/e /we/fig (1-Hz) during AF. For each
stimulus (n:2.S()-.S00) the paced AFCL was plotted against its coupling interval and
capture was determined by statistical shortening of the AFCL (RP^,.:7l±l7ni.s, R-.0.84.
p<().()l). The 5* /vrrt'/if/Y«' «//At* AFCL histogram as an index of RP^ was 77±12ms
(R':0.90.
Conclusions: During persistent AF with an AFCL of 98±l4ms. the RP*, determined by
mapping of synchronized premature stimuli (gold standard) was 7O±l2ms, with an
excitable period of 28±8ms. Although the indirect methods to measure RP^, all corre-
lated well with the gold standard, slow fixed-rate pacing seems the most attractive tech-
nique because of the ease of acquiring the data and the clear graphic result.
Key Words: Atrial fibrillation: Refractory Period; Excitable Gap.
Condensed Abstract
Methods to assess the refractory or excitable period during AF so far have been limited
to monophasic action potential recordings or extensive pace-mapping protocols. In the
present study we evaluated 5 different methods to measure the RP*, in the chronically
instrumented goal. During persistent AF with an AFCL of 98±l4ms. the RP^, deter-
mined by mapping of synchronized premature stimuli (gold standard) was 7()±12ms.
with an excitable period of 28±8ms. The results of the other method* all correlated well
with (he gold standard (activation maps).
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Introduction
Recently it has been suggested that the temporal excitable gap during AF is a critical
determinant for perpetuation and termination of AF.' In the presence of a short excitable
gap fibrillation waves are more likely to die out by encountering refractory tissue. On the
other hand, a short excitable gap may also promote the formation of new wavelets due
to an increase in the likelihood of intra-alnal conduction block. So far. determination of
ihe excitable gap during AF has been limited to the recording of monophasic action
potentials." Recently, RP^, has been measured directly by programmed electrical stim-
ulation. ' Cardioversion by class 1 drugs was found to be associated with a 2-3 fold
widening of the temporal excitable gap.'
The aim of the present study was to develop clinical uxils for the measurement of the
refractory period and temporal excitable gap during persistent AF'. live methods were
evaluated in a goat model of persistent AF using mapping as gold standard.
Methods
The goat model of AF was described previously." In eleven goats (5l±8kg) two plaques
(3.5x2.5cm. 30 electrodes, distance 4mm) were sutured to the free wall of the right (RA)
and left atrium (LA). One strip (6xlcm. 23 electrodes, distance 6-10 mm) was pulled
along Bachmann's bundle and sutured to both atrial appendages. The leads were
tunnelled subcutaneously to the neck and exteriorized by three 30-pin connectors. A
subcutaneous silver plate served as indifferent electrode. After recovery from surgery,
persistent AF was produced by a fibrillation pacemaker.'' After amplification (3(X)x) and
filtering (l-5(X)Hz) all unipolar atrial electrograms were stored on tape. Local activation
times were determined automatically by a custom-made algorithm detecting the maxi-
mal negative slope of the fibrillation electrograms. The goats were studied after 43±34
days of AF at a median AFCL of 98±l4ms. A central pair of electrodes on RA (n=7) or
LA (n=4) was used for stimulation. Biphasic stimuli of 2ms were generated by a con-
Mant current stimulator equipped with an amplifier recording a bipolar electrogram from
the pacing electrodes (Medtronic SP3111). The minimal current required for regional
entrainment of AF was taken as the threshold for stimulation.'
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METHODS TO MEASURE THE REFRACTORY PERIOD DURING AF
In Fig. I the five methods to measure RP.u are illustrated. Mapping was used as the gold
standard. Single premature stimuli of 4xthreshold were synchronized to the Fibrillation
waves at the pacing site. Capture was verified by activation maps around the pacing site.
In case of capture the atrium was activated in a radial fashion from the site of pacing.
A second method to measure RP*, is to apply premature stimuli during regional entrain-
ment of AF with an interval equal to the median-AFCL. The S1-S2 interval was changed
in steps of 2ms. Capture was determined by the latency and morphology of an electro-
gram recorded 4mm from the pacing site. In case of capture, the premature electrogram
showed a similar morphology and latency as during entrainment. The longest S1-S2
interval that failed to capture the atria was taken as the RP during entrainment of AF.
A third method to measure RP^i is to determine the statistical effect of synchronized
premature stimuli on the AFCL-histogram. Fach coupling interval was repeated 100
times. The shortest coupling interval resulting in a statistically significant difference in
AFCL-histogram was taken as the RP*, (Wilcoxon two-sample test).
A fourth method to determine RP\, is to pace the fibrillating atria at a slow fixed-rate
( I -H/) . Because of the irregularity of AF. slow pacing actually results in a series of
randomly applied premature stimuli. A computer algorithm was used to determine the
coupling interval at the pacing site (AF-S) and the associated AFCL at a neighboring
electrogram. At least 250 consecutive stimuli were analyzed. The shortest coupling inter-
val (classes of 5ms) resulting in a significant shortening of AFCL (Kolmogorov-Sminiov
one-sample test) was defined as the RP*,- Since this method was developed during
evaluation of the other techniques, it was applied only in the last 6 of 11 goats.
A fifth method to estimate RP^, is to determine the 5"percenlile of the AFCL-histogram.
constructed from at least 1(X) consecutive AF cycles from a unipolar RA or LA
electrogram.
THE EXCITABLE GAP DURING AF
The term "excitable gap" refers both to the excitable //.V.VMC between fibrillation waves
(spatial FCi) and the //>««• window of excitability during the AF interval (temporal EG).
We used the term rv«-j/«/>/f / v n W (EP^) to indicate the temporal excitable gap. With all
5 mot hods. F l \ , can bo calculated as the difference between the median-AFCL and
RP.v,. During fixed-rate pacing. l ^ \ , could be directly measured from the histogram of
the interval between the stimulus and the first response (S-AF). Whereas during sub-
threshold pacing the S-AF intervals were equally distributed, pacing at 4xthreshold
caused a gap in the S-AF histogram. The longest S-AF interval occurring less frequent-
ly than expected (95** -confidence interval) was taken as the EP^.
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Results
MAPPING OF THE REFRACTORY PERIOD DURING AF
In Fig.2 an example is given of the RP^ determined by mapping. In the upper panel, a
stimulus was applied 70ms after the pacing site was activated. The activation map shows
that the stimulus did not capture (he atrium. A stimulus with a slightly longer interval of
75ms (lower panel) resulted in capture as evidenced by radial spread of activation from
the pacing site. However, when stimuli with the same coupling interval were repeated
20x, sometimes capture occurred and sometimes not. In Fig.3 we plotted the percentage
of capture at different coupling intervals. At short coupling intervals (<65ms) the atrium
was never captured. Prolonging the interval from 65 to 90ms resulted in a progressive
increase in the probability of capture. A coupling interval longer than 90ms resulted in
I(X)% capture. The S-shaped curve shows that the RP^, is not a deterministic but a prob-
abilistic variable. We arbitrarily defined the RP^, as the shortest coupling interval that
captured the atrium at least 20'/r of the limes. This value represents the shortest of a
wider range of refractory periods during AF. In all goats the RP*, measured in this way
was 70±l2ms. The temporal variation in RP^, (5% to 95%-capture) was I9±4ms.
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REFRACTORY PERIOD DURING ENTRAINMENT OF AF
An example of the RP during entrainment of AF is shown in Fig.4. Entrainment was per-
formed at the LA with an SI-SI interval of 110ms (median-AFCL: 113ms). The unipo-
lar electrogram recorded next to the pacing site shows 8 entrained beats followed by a
single premature stimulus (S2). During entrainment, the activation maps revealed radial
spread of activation. An S2 stimulus of 90ms did not capture the atrium, whereas an S2
stimulus with a coupling interval of 92ms did capture the atrium (radial spread). For
determination of the RP*,. capture was verified by the morphology of the unipolar elec-
trogram next to the pacing site. In case of no capture, the electrogram showed a clear R-
wave and a variable time interval between the stimulus and the next activation. In case
of capture by the premature stimulus the latency and electrogram morphology were sim-
ilar as during entrainment of AF (no R-wave). The RP during entrainment. defined as the
longest S1-S2 interval that did not capture the atrium, was 77±17ms (6 goats).
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MEASUREMENT OF THE RP^ BY SYNCHRONIZED STIMULI
The response to synchronized stimuli was determined statistically by applying a prema-
ture stimulus KM) times. For each coupling interval a histogram of the paced-AFCL was
reconstructed from a neighboring elcctrogram. In Fig.5 an example is given of a prema-
ture stimulus with a coupling interval of 50ms. The control-AFCL histogram (sampled
one second before each premature stimulus) shows a normal distribution with a median-
AFCI. of 80ms. In contrast, the paced-Al-Cl. histogram showed a bimodal distribution.
Due to capture. M'.» of the AF-cycles were now shorter than 60ms. The Wilcoxon twtv
sample lest revealed a significant difference between the two histograms (p<0.05).
Premature stimuli with a coupling interval of <5()ms did not result in statistically differ-
ent AICI.-histograms. In 11 goats, the RP^, measured by the shortest coupling interval
yielding a statistically different AFCL was 7O±13ms. This value represents the .Y/I«/W
of a range of refractory periods during AF.
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MEASUREMENT OF THE RP^ BY FIXED-RATE PACING
An alternative way to determine RP.^ - is to stimulate the fibrillating atria at a slow fixed-
rate of I Hz, resulting in a series of randomly applied premature stimuli. In Fig.6 the
AFCL at an electrode close to the pacing site is plotted for all coupling intervals during
4 minutes of fixed-rate pacing (n:240). Two populations of data points can be clearly
distinguished. At shorter coupling intervals AFCL shows the normal variation (medi-
an:88ins). At longer coupling intervals the normal variation in AFCL was lost and. due
to capture, the paced-AFCL was now determined by the coupling interval of the stimu-
lus. At intermediate coupling intervals (48-69ms) only part of the stimuli captured the
atrium, illustrating the temporal variation in RPy. (grey column). In all goats the range
of temporal variation of the RP^ was 24±7ms. The shortest coupling interval producing
a significant shortening of AFCL. as determined by the Kolmogorov-Smirnov test, was
71 + 17 ms. This method was applied only in the last 6 of 11 goaLs since it was developed
during evaluation of the other techniques in the first 5 goaLs.
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Using fixed-rate pacing. EP„ can be directly visualised (Fig.7). During 16-17 minutes
of 111/ pacing all post-stimulus intervals (n:l(KK)) were plotted in a histogram. During
sub-thivshold pacing the S-AF intervals were equally distributed with a mean incidence
of 10.712.9 (95%-confidcnce interval between 4.9 and 16.5). When stimulus strength
was set at 4xthreshokl. the S-AF intervals were no longer equally distributed. Now. a
high incidence (n:.V>8) of short S-AF intervals was observed representing the latency
between stimulus and response during capture. At the same lime, the incidence of S-AF
intervals between 5 and 30ms markedly decreased. These intervals disappeared because
they were shortened by capture of the premature stimuli. The distribution of S-AF inter-
vals longer than 35ms did not change during pacing. The upper limit of the excitable
period was determined by the longest S-AF interval occurring less frequently than the
95%-confidence interval. In 6 goats. EPM measured in this way was 27±4ms. This value
represents the longest of a range of excitable periods during AF. Due to variation in
AFCL and Rl\ , . during many cycles HP*, will actually be shorter. This is illustrated in
Fig.7 by the atrial responses still occurring during the measured excitable period.
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THE P5-AFCL VALUE AS AN INDEX OF THE RP„
In 11 goats the median AFCL measured at RA or LA was 98±I4 ms. The 95'" and 5" per-
centile of the AFCL were 12()±I6 and 77±l2ms. The p5-value was used as an index of
RPM . This is based on the assumption that the shortest AF cycle lengths have no or only
a very short excitable period.
COMPARISON OF THE DIFFERENT MEASUREMENTS OF THE RP„
In Table 1 the values of RP^ as obtained by the 5 methods are listed for all goats. The
RP\, measured by mapping is considered as gold standard. All methods yielded an RP^K
between 70 and 80ms. During entrainment the RP was 4±5ms longer than the RP^
determined by mapping (77±17 vs 73±15ms, p=0.12). The correlation between the val-
ues obtained by entrainment and mapping was 0.88 (p<0.01). The RP^ determined by
synchronized stimuli yielded the same values as obtained by mapping (7O±13 vs 70±12;
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R':0.94; rxO.OI). The RP^ measured by fixed-rate pacing also gave a similar result
(7 I± I7 vs 73±l5ms; R-:0.84: rxO.OI). The 5'" percentile of the AFCL-histogram was
7±4ms longer than RP^, measured by mapping (77±12 versus 7()±12ms p<0.05) with a
correlation coefficient of 0.90 (p<0.01). Although the study was not designed to compare
measurements in RA and LA, AFCL and RP^, were consistently longer and showed
more variation in the RA (p:0.33-0.47).
Discussion
THE REFRACTORY PERIOD DURING ATRIAL FIBRILLATION
In the present study it was shown that the refractory period during AF exhibits a consid-
eraMc' fcfripuraf vdriiitron. Measurement of KP^, hy mapping or fixed-rale pacing
revealed a time window of 2O-25ms during which premature stimuli sometimes captured
I he atrium anil sometimes not (Fig.3 and 6). This probabilistic nature of RF\, is proba-
bly due to bcal-to-bcal variations in AFCL and direction of propagation. Also fragmen-
tation of fibrillation waves and electrotonic modulation of the action potential by disso-
ciated neighboring wavelets may cause temporal variation in RP*,."*The RP^ measured
by mapping was dell tied as the coupling interval resulting in >20<7r capture. Also the
other methods determined the "shortest" refractory period during AF. The values
obtained by the 5 methods ranged between 7()±I2 and 77±l7ms (70-80<£ of median-
AFCL). Although these measurements of the refractory period ignore the existing tem-
poral variation, they may be useful to explore the effects of changes in RP,,, on perpet-
uation and termination of AF. In addition, they might be of value to evaluate the spatial
variation in refractory periods during AF. The observed greater variability in AFCL and
RPv, in the right atrium may be associated with a more complex geometry, allowing 3-
D propagation during AF'.'"
COMPARISON OF DIFFERENT TECHNIQUES TO MEASURE RP„
The different methods to measure RP^, all have certain advantages and disadvantages
(Table 2 V Mapping i>l premature stimuli is the most reliable technique and can be regard-
ed as gold standard. However, due to its complexity and invasive nature, it can only be
used under exceptional circumstances. Measurement of the refractory period during
cntminment of AF has the advantage that it uses the conventional extrastimulus tech-
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nique (S1-S2) and that it can also be applied during paroxysmal AF. The somewhat
longer values obtained during entrainmcnl are probably due to electrolonic prolongation
of the action potential at the pacing site." On (he other hand, entrainmcnt of AF is not
always feasible during type III AF."" Statistical comparison of the AFCL-histogram
during synchronized premature stimuli is a highly objective way to determine the Rl\, .
However, it is a rather complex technique requiring specific expertise. The easiest way
to pace the atria during AF is slow fixed-rale pacing. The required equipment is limited
to a standard pacemaker, a multipolar catheter and software for data-analysis. The data
acquisition time is about 15 minutes during which no intervention of the elcctrophysiol-
ogist is needed. This method produces a clear graphic output from which both Rl\, and
EPu can be directly read out. It was applied only in the last 6 of II goats because the
technique was developed in the first 5 goats. Although (he p5-AFCL is even more sim-
ple, its reliability is questionable. During administration of class I drugs, the Kl\,
became considerably shorter than the p5-AFCL.
THE EXCITABLE PERIOD DURING ATRIAL FIBRILLATION
In the present study EP,^ ,„ calculated as the difference between AFCL (98±l4ms) and
RP,u (7()±12ms), was 28±8ms. The RP,\, measured directly during fixed-rate pacing
was 27±4ms (Fig.7). However, also EP^ must show a considerable temporal variation.
In our experiments the p5 and p95-AFCL were 77±I2 and 12()±l6ms. This variation
in AFCL (43±8ms) can not completely be explained by the variability in RP,^
(19±4ms). This implies that at short AF cycles the excitable period may become as
short as 7ms, whereas during long cycles the excitable period might be as long as
50ms. This beat-to-beat variability in EP,\, may play a role in perpetuation of AF.
The excitable period during AF might be explained by the different types of reentry
during AF.' In case an impulse circulates around an anatomic obstacle, EP*, is deter-
mined by the difference between the conduction time around the obstacle and the
refractory period within the reentrant circuit." In case of functional reentry. EP^, is
caused by the curvature of the circulating wavefront at pivot points. Due to the high
curvature, the excitatory current generated by the turning wavefront may not be
enough to make a rapid 180" turn''" and the resulting conduction delay creates an
excitable period in the returning limb of the turning wavefront." In addition, when
functional reentrant circuits are drifting through the myocardium, the excitable gap
will be shortened or lengthened by the Doppler effect.'" * In case of random reentry an
excitable period will arise at areas remote from the site of reentry due to the antero-
grade and retrograde conduction time to the site of reentry.' On the other hand, the
excitable period will be shortened by epicardial breakthrough of wavefronts propagat-
'ng in one of the pectinate muscles.'" The resulting short-circuit of epicardial reentry
may play an important role in perpetuation of AF, not only because of the 3-D nature
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of the reentrant process but also by narrowing its excitable gap.
Recently we suggested that EP*, might be a critical determinant for termination of AF.
Cardioversion of persistent AF by class I drugs was associated with a dose-dependent
widening of EP,,.' We speculated that widening of the EP^ decreases the number of
head-tail interactions between fibrillation waves, resulting in less dissociation and a
higher degree of organization of the multiple wavelets. Cardioversion of AF would
occur if multiple wavelets would fuse into a single wavefront whose circulating path-
way is ultimately interrupted. However, the possibility that under other circumstances
cardioversion of AF might be due to closure of the excitable period can not be exclud-
ed. Measurement of RP^i and EP^ during pharmacological cardioversion of AF using
the methods developed in the present study, may further elucidate the significance of
the excitable period for termination of AF.
Limitations
In the present study epicardial mapping was used to determine RPy,. Since no endocar-
dial recordings were made, the three-dimensional structure of the alrial wall, which
might play a role in the activation during AF, "' was not taken into account. Also, the
study was not designed to determine differences in AFCL, RP^, and EP^, at different
atrial sites. Variation in atrial architecture and underlying geometric discontinuities may
cause spatial variability in the RP and HP during AF. Future clinical studies measuring
RP^ with the use of a catheter will be needed to elucidate differences between RA and
LA. Another limitation is that measurements of RP^, were not compared with monopha-
sic nclion potential recordings. Therefore it remains unknown whether the EP^ is due to
u diastolic interval between (he successive action potentials during fibrillation. Since in
the present study RP^, was measured by chronically implanted epicardial electrodes,
clinical application of these methods must await validation using multipolar endocardial
catheters.
Table l. RP„ values obtained by different Methods.
Goat
1
2
3
4
5
6
7
8
9
10
II
Mean
SD
R2
Site
RA
RA
LA
RA
LA
LA
RA
RA
LA
RA
RA
AFCL
(median)
105
107
88
88
93
86
90
127
103
113
80
98
14
Refractory Period during AF
(ms)
Mapping
75
70
55
65
70
65
70
95
75
80
50
70(73)
12(15)
Entrainment
-
-
-
-
72
66
100
74
90
58
(77)
(17)
0.88*
Synchronized
Stimuli
80
70
55
65
70
65
70
100
70
75
50
70
13
0.94*
Fixed-Rate
Pacing
-
-
-
-
68
58
98
68
83
53
(71)
(17)
0.84*
p5AFCL
82
79
64
70
74
69
72
104
88
85
64
77
12
0.90*
Numbers between brackets indicate mean and standard deviation of goats 6-11; * p<0.01.
R2. correlation of the RPAF measured by the different techniques compared to mapping.
Table l. Comparison of Different Techniques to measure the
TECHNIQUES
Mapping
Entrainment
Synchronized Stimuli
Fixed-Rate Pacing
P5-AFCL
EQUIPMENT
- High-density mapping
- Programmed electrical stimulation
- Programmed electrical stimulation
- Multipolar catheter
- Stimuli synchronized to pacing site
- Multipolar catheter
- Fixed-rate pacemaker
- Multipolar catheter
- Recording of atria! electrogram
TIME
1 hour
15 min
30 min
15 min
3 min
ADVANTAGES
Gold standard
- Conventional S1-S2 pacing
- Also in Paroxysmal AF
Statistical determination of
- Easy to use
- Direct measurement of EP^
No pacing required
DISADVANTAGES
Only in exceptional
circumstances
Not always possible
Complex
Takes 15 minutes
Reliability
questionable
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General Discussion
New Perspectives for Atrial Fibrillation.
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Introduction
In recent years the interest in AF has increased explosively. One explanation might be
that the successful treatment of other arrhythmias has shifted the attention of cardiolo-
gists to the remaining challenges in arrhythmia management. Also an increased aware-
ness of the considerable morbidity and mortality associated with AF has caused a more
aggressive attitude towards attempts to restore normal sinus rhythm (rhythm versus rate
control).'' Finally, the discovery that 'AF begets AF" has emphasized that accepting atri-
al fibrillation to persist, may lead to irreversible atrial remodeling and a progressive
inability to treat the arrhythmia.'' These considerations have boosted the development of
both pharmacological and non-pharmacological therapies for treatment of atrial fibrilla-
tion." ''' Current non-pharmacological treatments of AF encompass atrial surgery, linear
and local RF ablation, single and dual site preventive pacing, and the implantable atrial
delibrillalor. However, despite all these efforts, present-day treatment of AF can still be
characterized as 'doing our best without knowing what is wrong'. To develop a more
effective strategy for treatment of AF. one needs to know the underlying pathophysio-
logical mechanisms in a given individual patient." In this respect, one has to realize thai
the diagnosis of atrial fibrillation is merely a description of a certain electrocardio-
graphic pattern which can be generated by different pathophysiological mechanisms.
Triggers, Initiators and Perpetuators
Three different players' are involved in the electropathology of atrial fibrillation: trig-
gers, initiators and pcrpetuators (Fig. I). Atrial fibrillation can be fr/,i«#<'/v</ by single pre-
mature stimuli originating from the crista terminalis, ostium of the coronary sinus, inter-
atrial septum and atrial free wall.' ' Also other onset-mechanisms like multiple prema-
ture beats, fival atrial tachycardia, atrial flutter and AV nodal tachycardia can start AF.
Trigger
o/ .4/" mi7H</r fnjf.ifrfs /A*i/ Win/ f/w urrAv/A-
Initiator Perpetuator
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Recent pioneering work by Haissaguerre et al. showed thai in patients with frequent
paroxysms of AF the vast majority of AF episodes (<Wf) were due to ectopic t'oci in the
wall of the pulmonary veins." This was continued and strengthened by other investiga-
tors and led to the introduction of radiofrequency catheter ablation of these pulmonary
vein foci.'^'* **"* However, if one believes that atrial fibrillation is due to a reentrant
mechanism, apart from the trigger also a substrate for initiation of alrial reentry is
required (in iff «for). Initiators arc thought to consist of areas of prolonged atrial refrac-
toriness, depressed or delayed conduction and/or a short alrial wavelength.* " Also fac-
tors such as local wavefront curvature and sink-source mismatch may be relevant for ini-
tiation of AF.*"' The area where atrial reentry occurs and AF is actually initialed may be
located remote from the trigger site. In normal atria AF is short-lasting and IN expected
to terminate spontaneously within minutes. A variety of different abnormalities in the
atria may act as /wr/x>fM<iK>r.v." Persistence of AF can result from atrial dilatation, elec-
trical contractile and structural remodeling, pro-fihrillatory effects of drugs and
pathoanatomica! changes like apoplosis. fibrosis and fatty degeneration/ ' "
Knowledge about how AF is initiated and perpetuated in a single patient could help in
chosing between the different treatment options. It is quite leasable that different under-
lying mechanisms of AF require different therapies (Fig.2). Such a <////m'H//'r// <//7/,t,'/;av/.v
of the underlying pathophysiological mechanisms (trigger-initiator-perpetuator) would
imply a clinical history, echocardiography, Holter monitoring, autonomic and invasive
electrophysiological testing. Although in many cases the underlying pathophysiology
will be multifactorial. in some patients a dominant pathophysiological mechanism might
be involved. Presently available catheters and sophisticated mapping systems allow
detailed analysis of the atrial electrophysiological substrate of AF, which might be use-
ful to choose the best treatment in individual cases."
Trigger Initiator Perpetuator
AAR Drugs + +
Atrial Surgery
Focal Ablation +++
Linear Ablation ++
Preventive Pacing ++ ++
fitfurr 2. Oijfrnrnf undVr/vinje m<"</ian/5m.( o / A f «"«/Hire oT/fc-rc/il /m/Mimr .irrarrxir.v /n />«//>«/( K»A "f
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The initiatior as Target for Non Pharmacological
Treatment of AF
Most cases of AF arc self-perpetuating and after a short time become independent of the
trigger site. It is widely accepted that atrial fibrillation is maintained by single or multi-
ple reentrant wavefronts. In a caprine model of AF we recently evaluated the substrate
for »>i/7/«»7w of atrial reentry by single premature beats.* Premature beats and initiation
of AF were found to be associated with critical conduction delay at Bachmann's bundle.
Also during rapid left atrial pacing, AF initiated remote from the rapidly firing focus."
The preferential conduction delay and fragmented low-voltage potentials recorded at the
mid-portion of Bachmann's bundle can result from non-uniform anisotropy, slow dis-
continuous conduction, longitudinal dissociation or conduction block.'* """ In the goat,
critical conduction along Bachmanns bundle might be explained by the considerably
longer refractory period measured at the mid-portion of BB. There is evidence that also
in human alria the inter-atrial septum plays a role in the genesis of AF. In several stud-
ies il was found to have a longer atrial refractory period and be an area of preferential
conduction delay of premature beats.•' •'""'" In patients with rheumatic heart disease the
earliest activity during induced AF was located near the inter-atrial septum (ostium of the
coronary sinus)/' It seems quite likely that due to ageing, atrial dilatation, fibrosis. etc...
also other areas than the inter-atrial septum may become an initiator' of AF.""
Localisation of areas of critical conduction delay and fragmentation and site(s) of earli-
est activation during onset of AF might provide a new target for modification of the sub-
strate of AF by KF ablation in patients. Because of their anisotropic properties and strate-
gic position. Bachmann's bundle and the inter-atrial septum are an attractive target for
radiolivi|ucncy ablation.'** In a canine model of sterile pericarditis. Kumagai et al.
showed that ablation of BB successfully terminated and prevented AF." In another
canine study Toiulo et al. showed that ablation of the mid-part of the inter-atrial septum
significantly reduced the likelihood of initiation of AF.* In the caprine model of AF we
showed that the site of initiation of AF might also be an optimal site for preventive pac-
ing. Pacing at the mid-portion of Bachmann's bundle significantly shortened the w indow
of iiulucibility of AF" by single premature beats, originating either from the right or the
left atrium.' These experimental findings suggest that Bachmanns bundle (area of crit-
ical conduction) may be an effective pacing site for preventive pacing. In patients with
recunvni AF. Padeletti et al. showed that atrial scptal pacing was successful in reducing
the Recurrences of AF (h.Vf in sinus rhythm after 17 months)." Similarly. Bailin et al.
showed that in patients with paamsmal AF. pacing at Bachmann's bundle had an incre-
mental benefit compared to right atrial pacing.'"
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Need for New Antiarrhythmic Drugs
Despite the success of non-pharmacological approaches, drug therapy will remain the
mainstay in the management of atrial fibrillation in Ihc general population.""" Non-phar-
macological approaches, although eagerly welcomed by cardiac arrhythmologists and
industry, are expensive, time-consuming and limited to a small subset of the general pop-
ulation.'" In Fig.3 we plotted the estimated number of patients with atrial fibrillation in
Belgium, according to age-related prevalence of AF."' The total number of people with
AF is estimated to be 121 .(XX). Of this population. 85** or actually 102.000 patients are
older than 65 years. In these elderly, the underlying pathophysiology of AF is expected
to be ;Nn////(<(7r>rr<{/ and AF is likely to recur or persist even after treatment of the initial
"culprit" mechanism. Most likely in these patients antiarrhythmic drugs will he needed
in an effort to attain the goal of arrhythmia management (reduction of AT burden and
prevention of symptoms, cerebral embolism and aggravation of heart failure).
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Until now, antiarrhythmic drugs have been limited and far from ideal." In the search for
the ideal drug the aim should be for superior efficacy, low risk of proarrhythmia. few
adverse events, no serious interactions and appropriate pharmacokinetics. New drugs
like ibutilide. dofetilide and a/imilide might offer additional benefit in cardioverting
AF." However, better ion channel-targeted drugs aimed at suppression of atrial foci or
prolongation of atrial refractoriness at slow heart rates may become equally important.
Also it must be better understood how antiarrhythmic drugs terminate AF (widening of
the excitable gap) and why they ultimately loose their efficacy for cardioversion of
AF." " The progressive inability of drugs to terminate AF might be due to an increase
in stability of the arrhythmia. '•' and/or a progressive loss of efficacy of antiarrhythmic
drugs by electrical remodeling." Also it remains to be seen whether anliarrhythmic
drugs restoring the shortened action potential in remodeled atria (such as I , , , agonists)
are able to promote restoration and maintenance of sinus rhythm in patients with alrial
f ibri l lat ion.""
Primary Prevention of AF
Since atrial fibrillation is widespread and associated with significant morbidity and mor-
tality, prevention seems essential in managing AF (Fig.3). Beyond finding effective
pharmacological and non-pharmacological treatments for patients w ith atrial fibrillation
(secondary prevention), it should be possible to prevent the arrhythmia in high-risk
patients (primary prevention). To focus on means for prevention necessitates considering
both clinical and pathophysiological factors. The Cardiovascular Health Study and the
Irammuham study have shown that some of the <7//HV<J/ risk factors for AF (e.g. systolic
blood pressure, blood glucose and valvular heart disease) are subject to control." The
most common clinical settings lor AF are hypertension and congestive heart failure.*'
Identification and aggressive management of these clinical risk factors may play an
ini|)ortant part in the primary prevention of AF. For instance, administration of
angiolcnsin converting en/.yme inhibitors is expected to reduce the incidence of atrial
fibrillation in patients with congestive heart failure.""" Primary prevention strategies
should also focus on the prevention of the «'/«vfm/wfAo/ojfif«/ factors of AF (trigger, ini-
tiator and perpetuator).-"" The inter-atrial septum (initiator) seems an attractive target tor
radiofrequency ablation in high-risk patients. Also the development of a substrate tor
self-perpetuation of AF. the point of no return, must be forestalled. The latter may be
accomplished by prevention of electrical remodeling, by either early cardioversion of AF
(implantable atrial defibrillator) or administration of antiarrhythmic drugs (calcium
blockade)."' On the other hand, therapies aimed at the prevention of fibrosis. atrial dis-
tension or age-related structural and electrical changes may offer incremental benefit.
New PERSPECTIVES FOR ATRIAI FIBRILLATION 141
Interest in atriai fibrillation is growing at an impressive rate and tools are becoming
uNuilable to study the electrophysiologic mechanisms responsible tor human atriai fib-
rillation. These tools could be the basis for the development of better pharmacologic and
nonphanmacologic ways for primary and secondary prevention of atriai fibrillation.
Patients already benefit substantially from these efforts. However, la-atmcnl of AI- will
remain a challenge and it seems likely that a few year» more will be required before the
"vicious circle" of AF is cut short.""'
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Summary
In the present thesis, we studied in the caprine model of AF. the role of AF-induccd
electrical remodeling in the management of atrial fibrillation.
In Chapter l the background to the present study is given. In recent years the interest
in At- has increased explosively. Hspecially the increased awareness of the consider-
able prevalence, morbidity and mortality associated with AI- has shifted the attention
of cardiologists to the oldest arrhythmia (atrial fibrillation: the oldest urrhythmia-thc
newest disease). The renewed interest in A I ' has boosted the development of both phar-
macological and non-pharmacological therapies for treatment of atrial fibrillation.
However, despite all these efforts, present-day treatment of AI-can still be character-
ized as 'doing our best without knowing what is wrong'. To develop a more effective
strategy for treatment of AF. one needs to study the underlying pathophysiological
mechanisms of AF. Or. as Thomas Lewis laconically suggested in 1902. ' / /«•
In Chapter 2 we described the cumulative effect of repeated paroxysms of AF on
inducibility and stability of AF in the goat. Two days of sinus rhythm were found to
be enough to recover completely from AF-induced electrical remodeling by 5 days of
atrial fibrillation. Also we observed no cumulative effect of repeated 5 day paroxysms
of AF on inducibility and stability. These findings highlight the importance of atrial
refractoriness as a potential target for antiarrhythmic strategies aimed at inhibiting the
self-perpetuation of AF.
In Chapter 3 we studied the effect of AF-induced electrical remodeling on atrial vul-
nerability by single atrial premature beats. In the goat. 2 days of atrial fibrillation was
associated with a marked widening of the window of inducibility of AF by single pre-
mature beats. Enhanced vulnerability in remodeled atria was due to a higher likelihood
of reentry in the presence of critical conduction at Bachmann's bundle. These findings
suggest that, during the first days of after cardiovcrsion of human AF, both early and
late premature beats can initiate early recurrences of AF. In patients, measurement of
the window of inducibility might be useful to predict likelihood of recurrence of AF
and to evaluate the efficacy of new treatment strategies.
In Chapter 4 we described the transient changes in atrial electrophysiology immedi-
Summary
ately after spontaneous termination of atrial fibrillation. In the goat, during the first 2
minutes of sinus rhythm after spontaneous termination of AF there was a transient
decrease in both alrial refractory period and conduction velocity. In remodeled atria,
the cumulative effect of electrical remodeling and this short-term changes created an
ultra-short alrial wavelength after termination of AF. In patients, immediate re-initia-
tion of AF (IRAF) can be explained by this transient supervulnerable phase. However
for immediate re-initiation of AF, the spontaneous occurrence of atrial triggers is at
least as important as a vulnerable substrate for reentry.
In Chapter 5 we determined the effects of different atrial pacing sites on the inducibil-
ily of AF by both right and left single atrial premature beats. It was found that, in
remodeled atria, preventive alrial pacing markedly could reduce the window of
inducibility of AF by single premature beats. The optimal site for preventive pacing
was found to be at Bachmann's bundle, close to the area of critical conduction delay.
Also in patients, the inter-atrial septum (Bachmann's bundle) might play a critical role
in the genesis of AF. Pacing at Bachmann's bundle might be optimal pacing to prevent
AF by both right and left atrial premature beats. Multi-site pacing seems of limited
additional value.
In Chapter 6 the effects of both digoxin and verapamil were evaluated on the duration
and electrophysiological properties of paroxysmal atrial fibrillation. In the goat, vera-
pamil but not digoxin exerted a direct pro-fibrillatory effect on paroxysmal AF.
Especially in remodeled atria, intravenous administration of verapamil converted
paroxysmal into persistent AF. This pro-fibrillatory effect of verapamil was due to
shortening of atrial refractoriness at high AF rates (rate-dependent shortening of
AF.RP). These findings suggest that in patients with paroxysmal AF. administration of
verapamil might reduce the likelihood of spontaneous termination of the atrial arrhyth-
mia. In contrast, digoxin is expected to reduce ventricular rate during AF without any
effect on atrial electrophysiology during AF.
In Chapter 7 we described five methods to determine the refractory and excitable peri-
od during chronic AF. During persistent AF with an AFCI. of 98±14ms. the RP,,, deter-
mined by mapping of synchronized premature stimuli (gold standard) was 7O±l2ms.
with an excitable period of 28±8ms. Although the indirect methods to measure RPu
all correlated well with the gold standard, slow fixed-rate pacing seemed the most
attractive technique because of the ease of acquiring the data and the clear graphic
result.
Summary
Finally, in the last chapter of this thesis (Chapter 8) the possible implications were
discussed. To develop a more effective strategy lor treatment of AF one needs to know
the underlying pathophysiological mechanisms of AF. Three diflerent "players" are
involved in the electropathology of AF: triggers, initiators und perpeluators. Although
in many cases the underlying pathophysiology wi l l he multil'actorial (e.g. elderly), in
some patients a dominant pathophysiological mechanism might prevail. It is quite fea-
sible that different underlying mechanisms of AF require diflerent therapies (differen-
tial treatment of AF).

«5«
Nawoord
Het werd me al duidelijk (ijdens mijn eerste jaar opleiding inwendige geneeskunde. Ik
zou "wetenschappelijk onder/oek" gaan doen. Hot waarom is moeilijk ml le loggen,
maar ik denk dat vooral hei gevoel primeerde dat ik iets moest bewij/en. mcer nog
legenover me/elf dan tegenover anderen. Sommige incnscn noenien het ambitic.
Dus zei ik op een dag legen Isabelle "Belleke. ik zou voor een jaartje naar Maastricht
kunnen. voor onder/oek in de clectrofysiologie. ...hot is een huiienkuns". We woon-
den toen nog in de Patijntjestraat te Gent en waren pas een jaar gctrouwd. l.ielste
Belle, je wist toen al beter en je vermoeden word bevesiigd toon ik uiteindelijk er nog
drie jaar langer bleef voor het vervolledigen van een doctoraat. Steeds heb je me
gestcund in mijn keuze. ot)k al was ik de godganse woken in Maastricht on liop ik ook
in do weekends hoofd/akclijk te piekeren. Hot was nioi altijd even goinakkolijk voor
jou. maar dankzij je zin voor rcaliteit en je enorme rclativcringsvermogen. is het ons
gelukt deze ommcweg te "ovcrlcven". Belleke. je mag er van op aan. ik blijf nu thuis
en alle liefdc en aandacht die je nog tegoed hobt, krijg jo duhhel en dik terug.
Het electrofysiologiseh centrum te Maastricht, onder leiding van Professor Maurlts
Allessie, was een weldoordachte carriere keuze. Het betraf een groot experimented
centrum, zeg maar het Mekka van de electrofysiologie van de läge landen. Maar al
vlug werd het me duidelijk dat dit geen normaal laboratorium was. Hei was vreemd
dat ik, opgegroeid in een hierarchisch feodaal stelsel. de "Professor" kon aanspreken
met Maurits...ik deed het dan ook heel stil tussen twee kuchjes in. Beste Maurils. ik
kan je niet genoeg bedanken voor de vele uren die we samen zaten. je enorme niveau
van begeleiding en je creativiteit. Velen waren bang van je. tussen ons klikte het allijd.
Ook Thea wil ik van harte bedanken, want de vele uren te Waalren en Frankrijk zitten
niet in het normale takenpakket van de vrouw van een promotor. Beste Maurits, ik
denk dat jij ecn belangrijke invioed gehad hebt en zult hebben op mijn verdere leven.
Dus als ik jou naam nu wat luider en duidelijker uitspreek is het cnerzijds omdal ik
zeifzekerder ben geworden maar anderzijds ook omdat ik heel fier ben dat ik je ken.
Het thuisfront was minstens even belangrijk voor mij. Mijn familie heeft me allijd
gesteund. Beste Moe, Va. Tine, Rudi, Hilde, Christof, Maarten, Caroline, Anneke,
Koen, Filip, Isabelle, Mama en Pappa, voorjullie was het waarschijnlijk nie! altijd
even duidelijk waarom ik niet normaal mijn opleiding cardiologie kon afmaken. Het
vertelt iets vlotter als je tegen nieuwsgierige mensen kan /.eggen "hij /.it in zijn laatstc
jaar opleiding cardiologie" eerder dan "we weten het niet goed, iets met geilen en
fibrilleren". Vaak waren jullie evenzeer met mijn toekomst begaan als ikzelf. Maar ik
mag je gerust stellen, ik sta nu in de kliniek, en er zijn weinig verschillen tussen de
(electrofysiologie van de) geit en de mens. Deze laatste /.in volledig in deze context
weliswaar.
Gedurende een werkweek. reed ik twee keer per week op en af tussen Gent en
Maastricht. In de vroege ochtend, sliep ik op verlaten parkings langsheen de autostra-
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de. In den beginne was het. als "kleine Belg" tussen de Nederlanders, niet altijd even
ecnvoudig. Maar vooral de laatsie jaren heerste er op het werk een gezellige sfeer en
drukte. Peter, Sabine, Frits, Jan, Frans, Jannie, Ullie, Cliff , Marcus, Shan, Paolo,
Ciaire, Theo, Ruuth, Leo, Natascha, Olivier, Bodo, Maurits aan jullie allen bewaar
ik de beste herinneringcn. Peter en Sabine waren ervan bij hei beginne bij. Met Peter
besprak ik de toekomst in de cardiologie die steeds zover afleek omdat de grole hin-
dernis van het proefschrift ons het zieht belemmerde. Bientje was onze troost, ze is
verstanding en realistisch en ze zorgde voor onze gemoedsrust door gewoon zieh zelf
te blijven. Jan. speciaal voor jou nog een dankwoord. want zonder jou was dit gewoon-
weg niet gelukt en was er geen proefschrifl.
Ondertussen werkte ik op woensdag op de aldeling ritmologie te Gent onder leiding
van Professor Jordaens. Beste Luc - je werkt nu ook in Nederland dus de voornaam
mag - j i j beul hei die ine in de beginne gemoliveerd hebt naar Maastricht te gaan. Jij
was de "//•/'##<'/•" en zoals je weet is dit een conditio sine qua voor elk /ww«m'/ i / pro-
ccs. Na je verhuis naar Rotterdam, verloren we elkaar uit het oog maar niet uit het hart.
Ondertussen was ik nog steeds welkom op het K)* in het UZ Gent, nu gelcid door
Rene Tavernier. Bedankt Rene, voor je realistische kijk op mijn onderzoekswerk en
je rüstige en secure munier van opleiding. Ook de anderen van het 10* wil ik bedan-
ken. Karden, Thea, Veerle, Etienne, Bert en Rudy. Het gebeurt niet vaak dat je op
«Wii dienst, zoveel aangename en hulpvaardige mensen samen aantreft.
Ook mijn vrienden wil ik bedanken, want /.oals de meeste weten draag ik ze allen hoog
in het vuundcl. Tijdens mijn doctoraatsjaren, brachten we de meeste tijd door aan Zee,
bij jeroen & Isabelle en Bruno & Sylvie. Vooral Peentje - tevens een collega docto-
rundus - wil ik bedanken. Ze heel't tot vervelens toc geluisterd naar verhalen betref-
fende mijn werk, maar ook en vooral als het ecus niet over het werk ging, vond ik bij
haar een luisterend mir. Ook Sylvie wil ik bedanken voor haar aanstekelijk enthousi-
asme en haar niet aflatende vraag of ik niets nieuws had uitgevonden die voorbij week.
Hier sluil ik al. Wellicht heb ik er velen niet bedankt, maar het was dan ook een
/x/woord en geen </«nAwoord. Ik laat de geitjes, parkings, manuscripten en
zenuwachtige congressen achter me en bli jf nu lekker thuis, bij Belleke en Charles.
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